Podcasts about Cochrane

Galactagogues and medications to boost milk production. Everything from oats to fenugreek to lactation cookies and prescription medications like metoclopramide and domperidone. Also, cow's milk protein allergy, reflux and baby's spit-up, the safety of alcohol while breastfeeding, and how to handle other prescription medications. Natalie Borden, an international board certified lactation consultant, joins Chris to debunk breastfeeding myths. Become a supporter of our show today either on Patreon or through PayPal! Thank you! http://www.patreon.com/thebodyofevidence/ https://www.paypal.com/donate?hosted_button_id=9QZET78JZWCZE   Email us your questions at thebodyofevidence@gmail.com.   Editor:    Robyn Flynn Theme music: “Fall of the Ocean Queen“ by Joseph Hackl Rod of Asclepius designed by Kamil J. Przybos Chris' book, Does Coffee Cause Cancer?: https://ecwpress.com/products/does-coffee-cause-cancer   Obviously, Chris is not your doctor (probably). This podcast is not medical advice for you; it is what we call information. References: Internet survey on patient use of lactation aides: https://pubmed.ncbi.nlm.nih.gov/37236347/ Cochrane 2020 on galactogogues: https://pubmed.ncbi.nlm.nih.gov/32421208/ 2023 RCT on lactation cookies: https://pubmed.ncbi.nlm.nih.gov/36921902/ The LactMed database: https://www.ncbi.nlm.nih.gov/books/NBK501922/

If your loved one with Alzheimer's disease is on one of the new treatment drugs, or you have been weighing whether to try them, the headlines from this spring may have stopped you cold. A major review from one of the most respected research organizations in the world concluded these drugs show no meaningful benefit. Researchers immediately fired back. And you are in the middle of all of it, as a caregiver trying to make real decisions for a real person. Your confusion is completely warranted. This is not a simple story. One headline says breakthrough. The next says it does nothing. But the full picture is more complicated than either side is telling you. In this episode I walk you through what the Cochrane review actually found, why experts are so divided on it, and the three questions you can bring to your loved one's neurologist to make a more informed decision for your specific family. Cochrane Collaboration Review (Full Study): https://www.cochrane.org/about-us/news/anti-amyloid-alzheimers-drugs-show-no-clinically-meaningful-effect  Get free weekly tools and tips in my newsletter, The Dementia Dose: https://tinyurl.com/dementiadose-podcast  Join the Care Collective: https://tinyurl.com/podcast-cc  ⏱ CHAPTERS  0:00 - The headlines that stopped caregivers  1:46 - Who these drugs are actually designed for  2:56 - What the Cochrane review found  5:26 - Why researchers are pushing back  7:50 - 3 questions to ask your loved one's doctor #dementia #dementiacaregiver #alzheimers #caregiving #alzheimersresearch --- Hi, I'm Dr. Natali Edmonds, a board-certified geropsychologist specializing in dementia care. Whether your loved one has Alzheimer's, frontotemporal, Lewy body, vascular, or mixed dementia, we believe that to create a dementia-friendly world, we must first create a caregiver-friendly world. This content is for educational purposes only and is not a substitute for professional medical advice. Always consult with a healthcare provider for medical guidance.

What happens when a Swiss-born business man who become a bus driver living in the Canadian Rockies decides it's never too late to follow a dream?In this inspiring episode of Most Memorable Journeys, I speak with Marcel Heim, a man whose life journey proves that reinvention has no age limit.Born in Switzerland and now living in Cochrane, Alberta, Marcel spent much of his professional life working in export, technology, project leadership, and business development before making the life-changing decision to move to Canada with his wife Irene. What followed was a journey filled with uncertainty, perseverance, culture shock, and ultimately the creation of a new life in one of the most beautiful places on earth.Today, Marcel still drives a public transit bus through the spectacular Bow Valley between Canmore, Banff, and Lake Louise, where he quietly observes the people who board his bus every day. Their stories, struggles, humour, and humanity became the inspiration for something entirely unexpected.At the age of 66, Marcel is releasing his debut country/Americana album, The Water Never Asked My Name, a collection of twelve songs inspired by real people, real roads, and the quiet moments most of us never notice. Using AI-assisted music production, Marcel transformed years of observations, memories, lyrics, and melodies into a finished album, proving that technology can become a powerful creative tool when guided by authentic human experience.In this conversation we discuss:• Growing up in Switzerland and his early life journey• Meeting the love of his life, Irene• The bold decision to leave Switzerland for Canada• The challenges of immigration and starting over from scratch• Life in the Canadian Rockies• Why he became a bus driver after a successful professional career• The fascinating people who inspired his songs• How artificial intelligence helped him achieve a lifelong dream• Why creativity, curiosity, and reinvention do not have an expiry date• The stories behind songs such as Swiss Boy in the Rockies, Five Minutes and a Heater, and The Water Never Asked My NameThis episode is a beautiful reminder that dreams don't retire when we do. Sometimes they are simply waiting for the right moment to emerge.As Marcel says through his music, the most meaningful stories are often found in ordinary people living ordinary lives.Listen now and discover how one man turned a lifetime of observations into music, proving that it is never too late to create something extraordinary.About Marcel HeimMarcel Heim was born in Switzerland and now lives in Cochrane, Alberta, with his wife Irene. After careers in export, information technology, leadership, and business development, he found inspiration in the everyday lives of passengers travelling through the Canadian Rockies. His debut album, The Water Never Asked My Name, will be released on July 3, 2026.Pre-save the album:distrokid.com/hyperfollow/marcelheim/the-water-never-asked-my-name

Amyloid-targeting monoclonal antibody treatments have ushered in a new era of Alzheimer's disease therapies after decades of research and clinical trials. A recent review published by Cochrane, a global, independent, non-profit network of researchers, professionals, patients and carers regarded as a gold standard for producing and promoting trusted, high-quality health information, has a different perspective on these therapies. The review found these treatments produce “little to no difference” in cognition and offer few benefits while increasing risks for adverse effects. Drs. Cynthia Carlsson, a clinical trialist, David Wolk, a clinician, and Henrik Zetterberg, a biomarker and disease biology expert, join the podcast to break down the review and their concerns, as well as highlight how this review could impact clinical care, research and public policy. Guests: Cynthia Carlsson, MD, MS, director, Wisconsin Alzheimer's Institute, Clinical Core leader, Wisconsin Alzheimer's Disease Research Center (ADRC), Louis A. Holland, Sr., Professor in Alzheimer's Disease, geriatrician, University of Wisconsin (UW) School of Medicine and Public Health; David Wolk, MD, director, Penn ADRC, co-director, Penn Memory Center, co-director, Penn Institute on Aging, professor of neurology, University of Pennsylvania Perelman School of Medicine; and Henrik Zetterberg, MD, PhD, professor of neurochemistry, University of Gothenburg, visiting professor, UW–Madison and University College London, Biomarker Core co-leader, Wisconsin ADRC Show Notes Read Cochrane's review, “Amyloid‐beta‐targeting monoclonal antibodies for people with mild cognitive impairment or mild dementia due to Alzheimer's disease,” on the Cochrane Library website. Learn more about Dr. Carlsson and Dr. Zetterberg at their profiles on the Wisconsin ADRC website and about Dr. Wolk at his profile on the Penn Memory Center website. Watch and listen to Dr. Carlsson's past episode, “A Closer Look at the Lecanemab Clinical Trials,” on our YouTube channel or on our website. Listen to Dr. Wolk's past episode, “LATE, Explained,” on our website. Listen to Dr. Zetterberg's past episode, “The Future of Fluid Biomarkers for Alzheimer's Disease and Related Dementias,” on our website. Connect with us Find transcripts and more at our website. Email Dementia Matters: dementiamatters@medicine.wisc.edu Follow us on Facebook and Twitter. Subscribe to the Wisconsin Alzheimer's Disease Research Center's e-newsletter. Enjoy Dementia Matters? Consider making a gift to the Dementia Matters fund through the UW Initiative to End Alzheimer's. All donations go toward outreach and production. Learn about Dr. Chin's book, When Memory Fades: What to Expect at Every Stage, from Early Signs to Full Support for Alzheimer's and Dementia, out June 2, 2026.

How do I know if my baby is getting enough milk? What is proper latching technique? How do you treat painful nipples? Natalie Borden, an international board certified lactation consultant, joins Chris to debunk breastfeeding myths. Become a supporter of our show today either on Patreon or through PayPal! Thank you! http://www.patreon.com/thebodyofevidence/ https://www.paypal.com/donate?hosted_button_id=9QZET78JZWCZE   Email us your questions at thebodyofevidence@gmail.com.   Editor:    Robyn Flynn Theme music: “Fall of the Ocean Queen“ by Joseph Hackl Rod of Asclepius designed by Kamil J. Przybos Chris' book, Does Coffee Cause Cancer?: https://ecwpress.com/products/does-coffee-cause-cancer   Obviously, Chris is not your doctor (probably). This podcast is not medical advice for you; it is what we call information. References: 1) 2014 Cochrane review on Interventions for treating painful nipples among breastfeeding women https://pubmed.ncbi.nlm.nih.gov/25506813/  

In this episode of Mind the Meds, Erica Marini, PharmD, highlights information from the European Stroke Organization Conference include encouraging data on asundexian(Bayer), a factor XIa inhibitor showing reduced recurrent ischemic stroke risk without increased bleeding, as well as positive results from three trials of tirofiban in acute ischemic stroke settings. On the multiple sclerosis (MS) front, Marini covers the FDA approval of ocrelizumab (Ocrevus; Genentech) for pediatric relapsing-remitting MS in children 10 and older, a new study supporting early use of high-efficacy agents in pediatric MS, and 2 Lancet publications on ocrelizumab — one examining higher weight-adjusted dosing (which did not improve disability progression) and one confirming benefit in a broader primary progressive MS population. She also briefly discusses PADOVA (NCT04777331), a phase 2b trial of prasinezumab in early Parkinson's disease, which failed to meet its primary end point.The bulk of the episode is a discussion with guest Millad Sobhanian, PharmD, BCPS, clinical pharmacy specialist in neurology at the University of Maryland, focused on Alzheimer disease. They cover dextromethorphan/bupropion (Auvelity; Axsome Therapeutics), newly approved in April 2026 for agitation associated with Alzheimer dementia. Sobhanian walks through key safety considerations—including additive NMDA antagonism if combined with memantine, cardiovascular risks from the bupropion component, and the ever-present black box warning on antipsychotics in dementia patients—while both note that the efficacy data, though statistically significant, shows modest clinical effect sizes compared to the threshold for meaningful within-patient change.The conversation then turns to lecanemab's subcutaneous initiation formulation (Leqembi Iqlik; Eisai, Biogen), whose FDA decision has been delayed to about August 2026 as regulators seek more data on bioavailability and ARIA monitoring in the at-home setting. Sobhanian shares his real-world perspective on anti-amyloid therapy, describing a patient population that is typically early-stage, high-functioning, and has a mean age of about 60 to 70 years, and emphasizing the pharmacist's role in expectation-setting around the modest but potentially cumulative slowing of cognitive decline. The episode closes with a thorough discussion of the April 2026 Cochrane review on amyloid-targeting monoclonal antibodies, which both Marini and Sobhanian find overly broad in its conclusions. They note limitations such as the inclusion of withdrawn agents like aducanumab (Aduhelm; Biogen), heterogeneous inclusion criteria across trials, and an 18-month study horizon that may be too short to capture the full benefit suggested by longer-term open-label extension data.Key Takeaways:1. New options for Alzheimer's agitation exist, but fit carefully into the treatment algorithm. Dextromethorphan/bupropion offers a novel NMDA-based mechanism for treating agitation in Alzheimer dementia, but its clinical effect size is modest, and it carries meaningful safety considerations—particularly around the bupropion component in elderly patients. Like all pharmacologic options in this space, it remains a later-line choice after nonpharmacologic interventions have been exhausted, and medication reconciliation is critical given its interaction potential with memantine and CYP2D6 inhibitors.2. Anti-amyloid therapies are imperfect but not ready to be written off. The April 2026 Cochrane review drew significant attention with its conclusion that anti-amyloid monoclonal antibodies produce only trivial cognitive benefits, but its findings are limited by the inclusion of older, withdrawn agents, heterogeneous trial populations, and an 18-month time horizon that may be too short to capture the full trajectory of benefit.3. The pharmacist's role in anti-amyloid therapy goes well beyond dispensing. As illustrated by Sobhanian's practice at the University of Maryland, clinical pharmacists embedded in neurology clinics play a critical role in patient selection, expectation-setting, ARIA counseling, and informed decision-making for patients considering anti-amyloid therapy—a complex, high-stakes treatment decision that these patients and their caregivers should never be navigating alone.

What if amyloid is only the match, tau is the brush fire, and neuroinflammation is the wildfire that causes the most damage in Alzheimer's disease?In this episode of Happy & Healthy with Amy, Amy explains why researchers are paying closer attention to neuroinflammation, what may be keeping the brain's immune system stuck in the “on” position, and why midlife is such an important window for protecting your brain.You'll learn how sleep, blood sugar, chronic stress, infections, oral health, and social connection may all influence the conditions that make the brain more—or less—flammable.What to Listen For[00:00] Why amyloid may be the match—but neuroinflammation is the wildfire. [02:30] What the Cochrane review found about anti-amyloid drugs. [04:30] Why timing matters in Alzheimer's disease. [07:00] Is neuroinflammation a side effect—or a driver? [09:00] Why inflammation itself is not the villain. [11:00] Meet microglia: the brain's immune cells. [14:00] Why gum disease matters for Alzheimer's risk.[18:00] The shingles vaccine and dementia risk. [22:00] Blood sugar, insulin resistance, stress, and sleep. [29:00] How to make your brain less “flammable.” Neuroinflammation may be one of the most important pieces of the Alzheimer's prevention puzzle because it connects so many things we often treat separately: sleep, stress, blood sugar, oral health, infections, diet, and connection.Listen to the full episode to understand what may be making your brain more “flammable,” then download the free RESTORED Protocol so you can choose one simple, evidence-based next step for protecting your brain.Mentioned in The EpisodeDownload the RESTORED ProtocolDownload The First Steps Guide for supporting a parent after Alzheimer's diagnosisRelated EpisodesAlzheimer's Prevention: What the Cochrane Review MeansAlzheimer's Drugs: Why Amyloid Removal May Not Be EnoughGum Disease, Menopause & Your Alzheimer's RiskSourcesRESOURCES:Book a FREE Discovery Call with AmyDownload After Mom's Alzheimer's Diagnosis: The First 8 Things to Know and learn how to support her with more calm, clarity, and confidence.Download the RESTORED Protocol: Eight Essential Protective Factors to Build an Alzheimer's-Resistant BrainSchedule your Breakthrough Roadmap session with AmyFollow Amy on Instagram @amylangcoaching  and on Facebook @amylangcoachingSubscribe to Amy's YouTube channel @happyandhealthywithamy

Jamie Hartmann-Boyce and Nicola Lindson discuss emerging evidence in e-cigarette research and interview Jonathan Livingstone-Banks, University of Oxford, UK. Associate Professor Jamie Hartmann-Boyce and Associate Professor Nicola Lindson discuss the new evidence in e-cigarette research and interview Dr Jonathan Livingstone-Banks lecturer & senior researcher in evidence-based healthcare in the Nuffield Department of Primary Care Health Sciences, University of Oxford. Dr Livingstone-Banks is part of the Tobacco Addiction Group within the Centre for Evidence-Based Medicine. He carries out research in the field of tobacco control and evidence synthesis and is involved in many Cochrane Reviews on tobacco control topics. Dr Livingstone-Banks is also a philosopher interested in the philosophy of evidence-based healthcare. In the May podcast Jonathan Livingstone-Banks discusses the findings of his overview of systematic reviews on the impacts of e-cigarette flavours. This is set against the backdrop of the first market authorisation of non-menthol, non-tobacco flavoured e-cigarettes in the US. The overview of reviews includes 32 reviews, 11 of which are higher quality and 21 of lower quality, and covers 1967 primary studies. Jonathan Livingstone-Banks outlines how e-cigarette flavours have the potential to impact a range of outcomes including e-cigarette and combustible cigarette use, safety profile, appeal, and perceptions of harm and how these may differ across different population groups. Overall, he considers that the data on flavours is limited and the impacts of e-cigarette flavours on e-cigarette and cigarette use are inconclusive. Further studies are needed to shed more light on this topic. Reference for the overview of systematic reviews discussed in this podcast: Livingstone-Banks J, Travis N, Conde M, Chen Y(C), Zi P, Jarman H, et al. The impacts of e-cigarette flavours: An overview of systematic reviews. Addiction. 2025;120(7):1327-1344. https://doi.org/10.1111/add.70017 This podcast is a companion to the electronic cigarettes Cochrane living systematic review and Interventions for quitting vaping review and shares the evidence from the monthly searches. Our searches for the EC for smoking cessation review carried out on 1st May 2026 found: 1 linked report (10.1186/s13063-026-09622-6). Our search for our interventions for quitting vaping review carried out on 1st May 2026 found: 1 new study (10.1016/j.acap.2026.103328) and 1 ongoing study (ACTRN12626000336381). For further details see our webpage under 'Monthly search findings': https://www.cebm.ox.ac.uk/research/electronic-cigarettes-for-smoking-cessation-cochrane-living-systematic-review-1 For more information on the full Cochrane review of E-cigarettes for smoking cessation updated in November 2025 see: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010216.pub10/full For more information on the full Cochrane review of Interventions for quitting vaping published in November 2025 see: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD016058.pub3/full

If your parent was recently diagnosed with Alzheimer's, you may have heard about the latest Alzheimer's treatments - Kisunla and Lequembi - being described as breakthrough "disease-modifying" drugs.And yes, the science is promising in some ways.But here's the part most families are not told clearly: a drug may successfully remove amyloid from the brain and still not create a meaningful improvement in memory, thinking, reasoning, or day-to-day function.In this episode, Amy explains why.This is not medical advice. It is education designed to help you ask better questions, advocate more clearly, and make decisions with your eyes wide open.You'll learn what happens in the brain long before symptoms appear, why amyloid is only one part of the Alzheimer's disease process, and why tau, neuroinflammation, and neurodegeneration matter so much when you're trying to make informed decisions for someone you love.What to Listen For[00:00] Why amyloid removal may not translate into meaningful improvement. [02:00] What the Cochrane review found about anti-amyloid drugs. [04:30] Why memory problems are not the beginning of Alzheimer's. [07:00] The Alzheimer's disease timeline. [10:00] Why treating amyloid after symptoms appear may be too late. [12:30] What tau does in healthy brain cells. [14:00] What tracks closely with cognitive decline. [16:30] What ARIA is and why it matters. [18:00] The role of neuroinflammation in Alzheimer's.[22:00] Questions to ask the neurologist before deciding. Mentioned in the EpisodeAlzheimer's Prevention: What the Cochrane Review MeansCochrane Review: Anti-amyloid Alzheimer's drugs show no clinically meaningful effectListen now, subscribe to Happy & Healthy with Amy, and share this episode with someone who is trying to make sense of an Alzheimer's diagnosis in their family.RESOURCES:Book a FREE Discovery Call with AmyDownload After Mom's Alzheimer's Diagnosis: The First 8 Things to Know and learn how to support her with more calm, clarity, and confidence.Schedule your Breakthrough Roadmap session with AmyFollow Amy on Instagram @amylangcoaching  and on Facebook @amylangcoachingSubscribe to Amy's YouTube channel @happyandhealthywithamy

Læger og sundhedspersonale, der bliver trænet i rygestopinterventioner, er mere tilbøjelige til at tilbyde patienter information, følge op og henvise til f.eks. kommunale rygestopkurser. Og det har stor indflydelse på sandsynligheden for, at patienterne stadig er røgfri seks måneder senere, viser et stort internationalt Cochrane-review. Det kan du høre om i denne udgave af Ugeskriftets podcast Gæst: Charlotta Pisinger, professor i tobaks- og nikotinforebyggelse, Center for Klinisk Forskning og Forebyggelse, Bispebjerg og Frederiksberg Hospital og Statens Institut for Folkesundhed, Syddansk Universitet Interview og redigering: Mie Brandstrup Tema: Frederik Ludwigs

God's Heart For The World, Part 2 - Dan Cochrane

From early adopters to today's booming simulator industry, “Inside Canada's Indoor Golf Boom; Past, Present and Future” explores how indoor golf has transformed the Canadian golf landscape. Host Nkele Martin sits down with Carl Fortin, co-founder of GolfIn, who had the idea for Golf Simulators when the technology was in its infancy, as well as conversations with PGA of Canada professionals Sean Casey in Oakville, Ontario, and Eric Locke in Cochrane, Alberta, who share their experiences opening and operating their own simulator businesses, the opportunities indoor golf has created for teaching professionals, and how technology is changing the way Canadians play and practice the game year-round.

Five longevity beliefs that millions have followed for decades have just been overturned by the latest research. Some of these will surprise you.In this explainer, Robert Lufkin MD walks through five of the most widely believed longevity myths — and what the most recent science actually says about each one. From genetics and middle age to antioxidants, alcohol, and caloric restriction, the evidence has shifted dramatically.CHAPTERS:00:00 — Introduction00:32 — Myth 1: Your Genes Determine How Long You Live01:51 — Myth 2: It's Too Late to Change After Middle Age03:24 — Myth 3: Antioxidant Supplements Prevent Disease05:22 — Myth 4: Moderate Alcohol Is Good for You07:04 — Myth 5: Caloric Restriction Is King08:50 — The Real Framework: Quality Beats Quantity09:18 — Final TakeawayKEY TAKEAWAYS:• Genetics accounts for at most 25–50% of how long you live• Quitting smoking before 40 eliminates ~90% of excess mortality risk• Antioxidant supplements have no benefit and may increase mortality• The protective J-curve for moderate alcohol disappears once you correct for the "sick quitter" effect• Caloric restriction's primate magic was rescuing animals from a high-sugar control diet• Diet quality matters more than diet quantitySTUDIES & SOURCES MENTIONED:• Herskind et al., Human Genetics 1996 — 2,872 Danish twin pairs heritability of longevity• Jha et al., NEJM 2013 — 21st-century smoking cessation and life expectancy• Saint-Maurice et al., JAMA Network Open 2019 — Adult life-course physical activity and mortality• Bjelakovic et al., Cochrane 2012 — Antioxidant supplements for prevention of mortality• Zhao et al., JAMA Network Open 2023 — Daily alcohol intake and all-cause mortality meta-analysis• Mattison et al., Nature Communications 2017 — Caloric restriction in rhesus monkeys (NIA / Wisconsin reconciliation)⭐ Enjoying the show? Please leave a 5-star review on Apple Podcasts — it takes 30 seconds and helps more people discover the science of health and longevity. Thank you!New episodes every Tuesday & Thursday. Subscribe so you don't miss one.Continue this conversation on Substack: https://robertlufkinmd.substack.comLies I Taught In Medical School — Free sample chapter: https://www.robertlufkinmd.com/lies/Web: https://www.robertlufkinmd.comYouTube: https://www.youtube.com/robertlufkinmdX: https://x.com/robertlufkinmdInstagram: https://www.instagram.com/robertlufkinmd/TikTok: https://www.tiktok.com/@robertlufkinLinkedIn: https://www.linkedin.com/in/robertlufkinmd/

The review embargo lifted today for The Mandalorian and Grogu, and the bag is more than a little mixed. Critics are either praising the film for its fun action adventure nature of the bounty hunter and his foundling or others are saying the film does not live up to the iconography that Lucasfilm and Star Wars is known for as well as having too small of a story for the big screen. With this being the first Star Wars film in seven years, a lot is likely riding on the performance of Din Djarin and Din Grogu. Ebon Moss-Bachrach has been quietly dishing details on not only Avengers: Doomsday but Secret Wars across his various media appearances in recent days. On Josh Horowitz's Happy Sad Confused podcast, the Thing actor admitted the Doomsday script he read didn't have a finished third act saying, "I don't think it had an ending,” and described the production as so compartmentalized and "interstellar" that he'd repeatedly go back to Joe Russo to have the multiverse threading re-explained. Then in a separate chat with the Dog Day Afternoon Broadway team, a play based on the 1975 film the actor is performing in, he casually dropped that Secret Wars filming kicks off in August 2026, right after his stage run wraps in mid-July.HBO set August 16 as the premiere date for Lanterns and dropped a new trailer that complicates the show's dark, earth-based mystery pitch with shots of Kyle Chandler's Hal Jordan in the classic Green Lantern uniform and what appears to be an off-world setting. The trailer also confirms Nathan Fillion is reprising his role as Guy Gardner and reveals Laura Linney in an undisclosed part opposite Aaron Pierre's John Stewart. Matt Reeves used a series of X posts last week to officially welcome Brian Tyree Henry and Sebastian Koch to Gotham for The Batman: Part II. They join the previously confirmed additions of Scarlett Johansson as Gilda Dent, Sebastian Stan as Harvey Dent, and Charles Dance as Harvey's father Christopher. Henry, a Marvel alum from Eternals who also memorably appeared in 2019's Joker, marks his second trip into the DC sandbox, while Koch is known for his prestige work appearing in films like Bridge of Spies. Michael continued another strong run at the box office this weekend and has now crossed $700 million dollars worldwide while the Devil Wears Prada 2 also continued its solid streak, crossing the $500 million dollar mark internationally. Mortal Kombat 2 crossed the $100 million dollar mark in its second weekend. Horror film Obsession opened very well with $23 million dollars worldwide, a big opening for a film from a first time director acquired out of a film festival. Marvel is making some changes to leadership in its comics division. The company has promoted Brad Winderbaum, already its chief of television and animation, to head of Marvel television, animation, comics and franchise. At the same time, David Abdo, former manager of Disney's music division, will transition to serve as Marvel's general manager, comics and franchise, reporting to Winderbaum. With the new top leadership coming in, that means that Dan Buckley, the longtime Marvel Comics head, is departing. Buckley will remain at Marvel through mid-2027 to support the leadership transition.HBO's Harry Potter series will already be recasting a role as production begins on season 2. Actress Gracie Cochrane, who portrays Ginny Weasley in the upcoming season 1 will not return for Season 2 of the series due to 'unforeseen circumstances,' Cochrane and her family revealed in a statement.Disney+ has begun development on Ella Enchanted, a TV series based on the 2004 Miramax fairytale film of the same name that starred Anne Hathaway, who will return to produce the series. Anyone But You writer Ilana Wolpert will serve as showrunner.A final look trailer for Prime's Spider-Noir, starring Nicholas Cage, was dropped today. 

Justin Cochrane is one of elite football's most respected coaches and a vital part of the England Men's backroom team. Justin's leadership focuses on reading a squad's emotional temperature and providing players the freedom to be themselves.In this episode, Justin shares the moving story of losing his wife Leeanne to cancer and how her selfless approach to her final days redefined his perspective. He discusses the "medicine" of football, explaining how returning to coaching weeks after her death provided the stability needed to carry immense grief while operating at the highest level.Justin also speaks to Jake and Damian about how personal trauma made him a better leader by shortening the gap between disappointment and recovery. From raising his three sons alone to preparing for a World Cup, Justin offers a masterclass in resilience, guided by Leeanne's final gift: the reminder to always have "someone to love, something to do, and something to look forward to."Postcode Lottery

In this episode, Ray Cochrane breaks down a reversible conductive glue from Newcastle University that could replace solder and finally make electronics recycling work. Additional stories cover China widening its clean energy lead, DeepMind’s AlphaEvolve scoring wins from genomics to Google’s database, Anthropic’s $200 million partnership with the Gates Foundation, Intel teaming up with McLaren Racing, and end-to-end encrypted RCS rolling out in beta. – Want to start a podcast? Its easy to get started! Sign-up at Blubrry – Thinking of buying a Starlink? Use my link to support the show. Subscribe to the Newsletter. Email Ray if you want to get in touch! Like and Follow Geek News Central’s Facebook Page. Support my Show Sponsor: Best Godaddy Promo Codes Get 1Password Full Summary Cochrane opens the show with a deep dive into Newcastle University’s reversible conductive glue, a water-based adhesive that could finally make electronics recycling economically viable. He frames the e-waste problem first: 62 billion kilos a year, with less than a quarter ever recycled. Then he walks through the silver nanoparticle chemistry, the lead-free angle on traditional solder, and the geopolitical stakes of critical mineral recovery. From there the episode pivots through energy, AI, hardware, open source, data research, space, science, and consumer privacy. A Reversible Conductive Glue That Could Replace Solder A team at Newcastle University has developed a water-based glue that conducts electricity well enough to replace solder. Unlike solder, however, the glue releases cleanly with a quick rinse of acetone or an alkaline bath. The breakthrough relies on silver nanoparticles suspended in a water-based binder. Consequently, components can be recovered intact, opening a viable path to electronics recycling at scale. Co-investigator Volker Pickert framed the second prize directly: solder has the best conductivity, but the best formulations contain lead. China Widens Its Clean Energy Lead A new Atlas Public Policy report shows Chinese firms accounted for 55 percent of $1.1 trillion in global clean energy manufacturing investment between 2019 and 2025. Battery manufacturing alone pulled in nearly half of that money. Meanwhile, U.S. companies have actively retreated from those same industries. With the Strait of Hormuz currently closed, supply chain ownership in solar, wind, and batteries matters more than ever. A separate Ember analysis showed Chinese solar panel exports doubled in March alone. DeepMind’s AlphaEvolve Scores Real Wins DeepMind published an update on AlphaEvolve, its Gemini-powered AI coding agent. The system cut genomic variant detection errors by 30 percent. Additionally, it lifted AC Optimal Power Flow feasibility from 14 to over 88 percent on the electrical grid. AlphaEvolve also found a better cache replacement policy in two days that would have taken human engineers months. Furthermore, it reduced write amplification in Google’s Spanner database by 20 percent. The pattern shows applied AI sticking, not as a chatbot but as a quiet optimizer. Anthropic and Gates Foundation Commit $200 Million Anthropic announced a four-year, $200 million partnership with the Gates Foundation across three pillars. The biggest pillar targets global health and life sciences in low and middle-income countries. Notably, the research scope includes polio, HPV, and preeclampsia. A second pillar covers AI in education across the U.S., sub-Saharan Africa, and India, in partnership with the Global AI for Learning Alliance. Finally, an economic mobility pillar focuses on agricultural productivity and crop benchmarks. Google’s AI Educator Series Launches Free Google rolled out the first 20-plus sessions of its AI Educator Series this week. The free AI literacy training targets the roughly 6 million K-12 and higher education teachers across the U.S. Modules are designed as short, snackable trainings teachers can finish in a prep period or a lunch break. Additionally, stackable workshops let educators build credentials over time. Importantly, the program requires no institutional subscription. Amazon Bedrock Prompt Optimization Goes GA Amazon Bedrock dropped its Advanced Prompt Optimization tool, now generally available across most major regions. The feature rewrites prompts to perform better on specific models and automates prompt migration when switching between models. Furthermore, a built-in evaluation feedback loop lets users benchmark against up to five models side by side. The default judge model is Claude Sonnet 4.6. Consequently, teams can stop hand-tuning string templates and focus on product work. Sponsor: GoDaddy Economy hosting $6.99/month, WordPress hosting $12.99/month, domains $11.99. Website builder trial available. Use codes at geeknewscentral.com/godaddy to support the show. Arm AGI CPU and Red Hat Go Production-Ready on Agentic AI Arm and Red Hat expanded their collaboration around Arm’s AGI CPU, which is Arm’s branding for its agentic AI chip family. The deal brings Red Hat Enterprise Linux and OpenShift to the chip as a production-ready stack. Hardware specifications include 136 Neoverse V3 cores, 96 PCIe Gen6 lanes, and 12 channels of DDR5-8800 memory in a 300-watt thermal envelope. Availability lands in Q4 through Supermicro, Lenovo, and ASRock Rack. Intel Becomes McLaren Racing’s Official Compute Partner Intel announced a multi-year deal as the official compute partner for McLaren Racing. The agreement covers the McLaren Mastercard Formula 1 team, Arrow McLaren IndyCar, and McLaren F1 Sim Racing. Trackside edge compute will power real-time race decisions, while Xeon and Core Ultra silicon drive Computational Fluid Dynamics and digital twin work. Consequently, design iterations that once took weeks now collapse to days. The deal puts Intel silicon in front of every CTO watching a Grand Prix. Rust Lands 13 Google Summer of Code Projects The Rust Project landed 13 accepted projects in Google Summer of Code 2026. Out of 96 proposals, a 50 percent jump from last year, the project selected 13. Notably, three returning contributors from prior years are back. Mentors flagged a noticeable share of AI-generated submissions as a growing challenge. Furthermore, the real bottleneck remains mentor capacity rather than funding. GitHub Innovation Graph Maps Digital Complexity Researchers used GitHub Innovation Graph data to predict GDP, inequality, and emissions through the Economic Complexity Index, or ECI. Countries are compared to kitchens; the more variety and sophistication in software output, the higher the score. Germany ranks first, followed by Australia and Canada. The U.S. lands at sixth. However, the dataset only captures public GitHub activity, leaving most proprietary software invisible. NASA and Eta Space Prepare Cryogenic Fuel Demo NASA is teaming with Eta Space on an in-orbit demonstration called LOXSAT, short for Liquid Oxygen Flight Demonstration. The nine-month mission tests cryogenic fluid management techniques required for in-space propellant depots. Launch is no earlier than July 17 aboard a Rocket Lab Electron from the Mahia Peninsula in New Zealand. Successful refueling in orbit could reshape what is possible for deep-space missions to the Moon and Mars. Stealth Magma Surge Under São Jorge Surprises Researchers Researchers in the UK and Spain published in Nature Communications on a 2022 magma surge under São Jorge Island in the Azores. The surge climbed from more than 20 kilometers underground to 1.6 kilometers below the surface. Surprisingly, most of the thousands of earthquakes happened after the magma stalled, not during the climb. Consequently, scientists are calling it a stealth surge and a failed eruption. A primed magma chamber now sits closer to the surface than before. End-to-End Encrypted RCS Begins Rolling Out Apple and Google led a cross-industry effort to roll out end-to-end encryption for RCS messaging. As of May 11, the feature is rolling out in beta on both platforms. Importantly, encryption is on by default and auto-applies to new and existing conversations. A lock icon in the chat indicates active end-to-end encryption. This quietly raises baseline privacy for billions of cross-platform messages. Cochrane signs off with the usual ecosystem mentions: GNC Insider at geeknewscentral.com/insider, the show newsletter, and modern podcast app recommendations at podcastapps.com. The post A Reversible Glue that could Replace Solder #1865 appeared first on Geek News Central.

  In this episode, Ray Cochrane leads with Mozilla shipping Firefox 150 with 271 patched bugs found by Anthropic’s Mythos system, the first major real-world deployment of the AlphaGo-Moment cybersecurity tooling. He also covers a 9-year dormant Linux kernel root, a college student stopping Taiwan’s high-speed rail with a software-defined radio, GitHub MCP secret scanning going GA, the NVIDIA NeMo lawsuit surviving its motion to dismiss, the Hugging Face Reachy Mini app store, Anthropic’s Auto Mode for Claude Code, and the 4-gigabyte AI model Chrome silently installed on your computer. – Want to start a podcast? Its easy to get started! Sign-up at Blubrry – Thinking of buying a Starlink? Use my link to support the show. Subscribe to the Newsletter. Email Ray if you want to get in touch! Like and Follow Geek News Central’s Facebook Page. Support my Show Sponsor: Best Godaddy Promo Codes Get 1Password Full Summary Cochrane opens the show with the AlphaGo Moment moving from theory into production. Mozilla shipped Firefox 150 this week with 271 patched bugs that Anthropic’s Mythos system found. Furthermore, the broader episode threads a clear pattern: AI tooling is reshaping security, developer workflows, and consumer software faster than the surrounding ecosystem can absorb it. The show closes on the four-gigabyte AI model Chrome installed on a billion machines without explicit consent. Mozilla Ships 271 Mythos Bugs in Firefox 150 Mozilla ran Anthropic’s restricted Mythos system against the Firefox 150 codebase before shipping. The result: 271 found bugs (180 high severity, 80 moderate, 11 low) baked into the release. However, the bigger number is the year-over-year jump. April 2026 shipped 423 total Firefox security fixes versus 31 a year prior. The breakdown for April: 271 from Mythos, 41 from external researchers, and 111 from other internal sources. Cochrane is sticking to his guns on calling this the AlphaGo Moment for cybersecurity. Skeptics argue Mythos is industrial-scale fuzzing because most found bugs sit in memory-safety territory. However, his counter is the velocity itself. Furthermore, he frames the resistance as carriage-versus-cars: humans-first research still grounds the tool, but throughput is the win. The Firefox CTO put it directly: defenders finally have a chance to win, decisively. For developers asking whether Mythos changes anything if they already run fuzzers, Cochrane’s answer is yes, and not even close. Additionally, he notes Mythos is restricted-access. The broadly available tier is Claude Opus 4.7, which Mozilla used since February before getting onto the restricted program for the Firefox 150 cycle. Run Opus 4.7 first. Sponsor: GoDaddy GoDaddy has been sponsoring this show for over twenty years. Economy hosting starts at $6.99/month, WordPress hosting at $12.99/month, and domains at $11.99. Use codes at geeknewscentral.com/godaddy for exclusive deals and to directly support the show. Copy Fail: 9-Year Linux Kernel Bug, 732 Bytes to Root A 9-year-old dormant Linux kernel bug got disclosed April 29 as CVE-2026-31431. Researchers published a 732-byte Python script that roots every major Linux distribution shipped since 2017. Additionally, CISA added the CVE to its Known Exploited Vulnerabilities catalog on May 1 with a May 15 federal deadline. The bug lives in the kernel’s crypto socket layer through the AF_ALG AEAD interface, originating in a 2017 in-place crypto optimization that lacked bounds checking. Cloudflare published their post-mortem this week. Their first instinct was to remove the kernel module entirely. However, service dependencies forced a workaround instead. Cloudflare resumed normal patched-kernel reboot automation across their 330-city fleet on May 4, with manual reboots and rollouts continuing after. Taiwan Rail Stopped by a 23-Year-Old With a Software-Defined Radio A 23-year-old Taiwanese university student with the surname Lin spoofed a TETRA general alarm signal on April 5, stopping trains on Taiwan’s high-speed rail. The accomplice supplied the radio parameters. Both were arrested by month-end. Lin posted NT$100,000 bail; the accomplice posted NT$80,000. The incident hit at 11:23 PM during the Qingming holiday weekend, stopping three revenue passenger trains plus one deadhead. Furthermore, the system has been in service for 19 years without rotating its cryptographic parameters once. Cochrane notes this is exactly the type of long-dormant infrastructure flaw that Mythos-class tooling catches, if anyone bothers to point it at the wires we already have. GitHub MCP Secret Scanning Goes GA GitHub’s secret scanning in the MCP server hit GA on May 5, with dependency scanning entering public preview the same day. Both released after a seven-week public preview run starting March 17. Additionally, the feature lets MCP-compatible coding agents (Copilot CLI, VS Code, JetBrains, Claude Code, Cursor, Windsurf) detect exposed secrets before commits or pull requests. Findings are ephemeral. They surface only in the current chat session and don’t persist as GitHub alerts. Sources disagree on scope: GitHub’s GA changelog says repo-level or org-level settings work, while the docs say only org-level applies. Cochrane flags the open question of whether MCP prompt injections could be exploited to send discovered secrets elsewhere. Subquadratic Debuts a 12-Million-Token Context Window Miami-based Subquadratic emerged from stealth on May 5 with a $29 million seed round and a reported $500 million valuation. Their model, SubQ 1M-Preview, runs on a new Subquadratic Sparse Attention architecture (their technical writeup calls it Selective Attention; same acronym, different second word). The headline claim: a thousand-times reduction in attention compute at 12 million tokens versus frontier models. However, that figure is vendor marketing math. There is no peer-reviewed paper, no public weights, and no independent benchmark replication. Researchers are demanding independent proof. Furthermore, CTO Alex Whedon’s pull line, “Retrieval / RAG plumbing is a waste of human intelligence,” signals how aggressively they want to position against retrieval-augmented architectures. ChatGPT Goblins, China’s “Catch You Steadily”: Sycophancy Is Universal Last week’s ChatGPT goblin obsession has a Chinese-language twin. The model overuses a phrase translating as “I will steadily catch you.” Additionally, a new Stanford and CMU study called ELEPHANT shows social sycophancy is universal across all 11 LLMs tested with 2,400-plus participants. Models endorsed users 49 percent more than humans did, and 47 percent even on harmful prompts. Alibaba’s Qwen and DeepSeek topped the rankings. Cochrane notes sycophancy is obvious once you’re aware of it but tricky to dissuade. Even with explicit instructions, longer context windows can reintroduce the behavior as the instructions get diluted. Furthermore, the trap is believing you’ve handled it. Once you think you’ve got it under control, you’re more prone to being influenced because you stopped watching for it. NVIDIA NeMo Lawsuit: Judge Tigar Denies Motion to Dismiss Three authors filed Nazemian v. NVIDIA in March 2024, alleging NVIDIA used The Pile and Books3 (approximately 196,640 pirated books) to train its NeMo AI framework. NVIDIA’s defense relied on the Sony v. Universal Betamax doctrine, arguing NeMo’s training scripts are general-purpose tools like a VCR. This week, Judge Tigar denied NVIDIA’s motion to dismiss in the Northern District of California. The headline quote: NeMo’s training scripts “have no other purpose than to speed up the process of infringement.” Furthermore, the judge rejected the VCR analogy outright. NeMo’s scripts are not general-purpose tools; they were allegedly purpose-built to ingest pirated material. Cochrane reads the Betamax framing as legal-jargon arbitrage rather than honest defense. The Humanoid Robot Market Is Smaller Than the Hype Michael Barnard at CleanTechnica argues that scenario-math against the global labor market puts realistic humanoid TAM at $200 billion to $1 trillion, not $20 trillion. Near-term wins cluster in warehouses, not homes. Additionally, the framework weighs dexterity burden against human-proximity safety burden. Real opportunities cluster where both burdens are low. Cochrane connects this to last week’s reservations about humanoids in the household. Furthermore, the risk profile is the issue: these robots aren’t prepared for every scenario, can’t make dynamic decisions, and one software update can change the definition of “safe.” Hugging Face Launches Reachy Mini App Store Hugging Face launched an open-source app store for the Reachy Mini robot this week, $299 for the Lite tethered version and $449 wireless. There are 200-plus community-built apps at launch from over 150 creators, with nearly 10,000 Reachy Minis cumulative shipped. Additionally, apps are forkable, with the default agent (ML Intern) able to modify, write, test, and ship code on any existing app. Examples at launch include an office receptionist built in under two hours, a Reachy Phone Home anti-procrastination app, baby-monitor-style apps, a cooking assistant, and a 78-year-old Joel Cohen’s voice-controlled CEO peer-group app. Pollen Robotics, the company behind Reachy, was acquired by Hugging Face on April 14, 2025. Bebop the Humanoid Robot Delays Southwest Flight 1568 A 4-foot, 70-pound humanoid robot named Bebop delayed Southwest flight 1568 from Oakland to San Diego by more than 73 minutes on April 30. The crew flagged the lithium battery as oversized. Furthermore, the battery was reportedly four times the cabin limit. Bebop belongs to Dallas-based Elite Event Robotics, which bought a full-price cabin ticket because the robot exceeded checked-baggage weight. Bebop danced for passengers at the gate before boarding. However, Southwest had Elite remove the batteries before departure, and replacements were overnighted to Chicago for the next event. Cochrane flags the obvious: batteries have always been flagged in aviation, so forgetting that with a humanoid robot in tow is a strange miss. Ouster Rev8: Native Color Lidar With Google, Volvo, Skydio Stating Intent Ouster announced the Rev8 OS Family on May 4 in San Francisco. The sensors fuse depth and color via SPAD detectors (single photon avalanche diodes) on Ouster’s custom L4 and L4 Max chips. Google, Volvo Autonomous Solutions, Skydio, Liebherr, Epiroc, and PlusAI have stated intent to adopt, though nothing is formally signed. Specs include 48-bit color, 116 dB dynamic range, and pre-fused 3D colorized point clouds. The OS1 Max gets 500-meter max detection. Available to order today and shipping this quarter, with no pricing disclosed. CEO Angus Pacala in his TechCrunch interview: “The goal is to obviate cameras. There’s no reason that one sensor can’t do both.” TagTinker Lets a Flipper Zero Mess With Electronic Shelf Labels A new Flipper Zero app called TagTinker uses infrared signals to push images and text to electronic shelf labels. Additionally, these are the same kind of price tags grocery chains are starting to use for surveillance pricing. The app and GitHub repo went public this week. Maryland’s HB 895, signed by Governor Wes Moore, takes effect October 1 as the first-in-nation surveillance pricing law. It covers food retailers and third-party food delivery service providers. Furthermore, ESLs use the same IR signaling as TV remotes with weak security. The dev’s disclaimer states it’s strictly for educational research, security curiosity, and displaying digital art on hardware you legally own. Fitbit App Becomes Google Health, Plus Fitbit Air, Plus Google Fit Sunset Google announced May 7 that the Fitbit app becomes Google Health on May 19, rolling through May 26. The launch ships with the new $99.99 Fitbit Air screenless tracker and the long-rumored Google Fit shutdown. Additionally, the four-tab interface (Today, Fitness, Sleep, Health) bundles a Gemini-powered AI Health Coach. Coach is premium-gated at $9.99/month or $99/year. Medical records integration is US-only at launch. The Fitbit Air gets up to one week of battery life and 50-meter water resistance. However, Cochrane flags conflicting privacy framing: Google’s AI summary bullets say “your data stays private,” but the actual document copy says only “committed to not using Fitbit user health and wellness data for Google Ads.” Those are not the same statement. Russinovich on Why Win32 Won and WinRT Didn’t Microsoft Azure CTO Mark Russinovich said via Microsoft Dev Docs video that Win32, the 1995 API, is still foundational to Windows 11. WinRT, the modernization replacement, “didn’t play out the way a lot of people expected.” Mostly clickbait framing per Windows Latest, but the substantive angle is real. Microsoft is pivoting back to native WinUI 3 development after years of pushing developers toward WebView2 and Electron. Additionally, Electron-based apps are known for insane RAM usage, and everyone is hurting for RAM right now. Furthermore, the bigger open question is whether Electron survives the test of time, especially with the React engine reportedly being rewritten in Rust. “Tabula Plena”: The Brain Starts Full, Not Blank A Nature Communications study from the Institute of Science and Technology Austria found that the mouse hippocampal CA3 recurrent network begins densely connected and refines through pruning. ISTA’s press release frames this as “tabula plena,” meaning full slate, counter to tabula rasa. The paper published April 21. First author Victor Vargas-Barroso and senior author Professor Peter Jonas studied mice at three developmental stages. Furthermore, the “starting overloaded enables faster sensory integration” framing is Jonas’s hypothesis from the press release, not a paper conclusion. Cochrane closes on the bigger question: did we have human growth and experience mapped wrong from the start? The Aqueous Battery You Can Pour Down the Drain A Chinese research team led by Professor Chunyi Zhi at City University of Hong Kong built an aqueous battery using a custom organic polymer electrode plus neutral magnesium and calcium salts (food-grade tofu coagulants) as electrolyte. Published in Nature Communications on February 18. Numbers to know: 120,000-plus charge cycles, full-cell energy density of 48.3 watt-hours per kilogram. That’s well below typical lithium-ion. However, post-cycling analysis showed only magnesium, calcium, chlorine, carbon, and copper, with no heavy metals. The cell complies with US RCRA, ISO 14001, and China’s GB 18599-2020 for direct environmental disposal. Additionally, the “300-plus years” framing is journalists extrapolating from the 120,000 cycles, not a paper claim. ResoNix Klippel Tests Expose Car-Audio Spec Lies Nick Apicella, founder of ResoNix Sound Solutions in Stony Point, New York, spent around $23,000 on independent Klippel LSI and TRF testing of 40 subwoofers. He published 21 results showing widespread misrepresentation of Xmax (excursion) and thermal/power-handling claims. Test data published in three batches between December 2025 and January 2026. Specifics: Wavtech thinPRO12 claimed 20 mm of excursion but delivered 8.85 mm, scoring 15 out of 100 on marketing accuracy. One driver hit 44 percent of advertised excursion. Another tripped thermal protection at half its rated power. Additionally, nine of 21 drivers scored below 50 out of 100. Brands tested include JL Audio, Sundown, Focal, Morel, Audiofrog, Adire, Stereo Integrity, and Dynaudio. Conflict-of-interest flag: ResoNix’s own GUS-15, 12, and 10 prototypes conveniently rank one, two, three. JetBrains Opens 2026 Developer Ecosystem Survey JetBrains opened the 10th annual Developer Ecosystem Survey this week. It takes about 30 minutes, with prizes including a MacBook Pro 16-inch and a $1,000 Amazon gift card. Anonymized raw data is published publicly, and cumulative scale is 100,000-plus developers across recent years. Additionally, the survey is going fully anti-AI: “evil bots, dishonest respondents, and AI agents will be excluded from prize distribution.” Cochrane is curious whether TypeScript holds its 2025 crown after knocking Python off, and whether Rust shows real growth given the wave of LLM-driven Rust rewrites in the past few months. Anthropic’s Claude Code Auto Mode Goes Live Anthropic launched Auto Mode for Claude Code roughly six weeks ago. Claude Code’s previous behavior required user approval for most file modifications and command executions, generating heavy approval-fatigue complaints during longer sessions. Auto Mode is the answer: Claude can run multi-step development tasks without per-action approval. Additionally, the architecture is a two-stage classifier, with stage one a fast yes/no filter and stage two doing chain-of-thought on flagged actions. Cochrane runs his own Claude Code in YOLO mode but with custom rejection rules baked into settings to block commands he doesn’t want, even with skip-permissions on. He recommends configuring settings as the actual policy layer rather than relying on classifier judgment alone. Furthermore, recent posts about Claude deleting websites or wiping production databases reinforce why the settings layer matters more than the auto-mode toggle. Chrome Quietly Installed a 4GB AI Model on Your Computer Google Chrome silently downloads on-device AI model weights (Gemini Nano family) to a `weights.bin` file in the OptGuideOnDeviceModel directory, around four gigabytes in Alexander Hanff’s audit. Furthermore, the model re-downloads if you delete it. Hanff timed his own install at 14 minutes 28 seconds on macOS. Affected platforms include Windows, macOS (including Apple Silicon), and Linux. Hanff frames this as a multi-front legal violation: a direct breach of Europe’s ePrivacy Directive, two articles of GDPR, and an environmental harm of a magnitude that would be notifiable under the Corporate Sustainability Reporting Directive. At one billion users, the four-gigabyte distribution represents roughly 240 gigawatt-hours of network and storage energy paired with about 60,000 tonnes of CO2-equivalent emissions. However, no EU regulator action or formal complaint has surfaced as of this episode. The model powers on-device features (email writing, scam detection, summarization, smart paste, tab grouping) but not the visible AI Mode button, which routes to the cloud. To disable, Cochrane recommends Chrome Settings, then System, then On-device AI, toggle to off. Two more paths exist via `chrome://flags` or a Windows registry edit. Cochrane closes the show with show housekeeping: GNC Insider at geeknewscentral.com/insider, email at geeknews@gmail.com, newsletter signup at geeknewscentral.com, and Pocket Casts as a solid modern podcast app pick. Have a wonderful night. The post Mozilla Meets Mythos #1864 appeared first on Geek News Central.

In this episode, Ray Cochrane leads with GitHub’s worst reliability month on record and the AI infrastructure pressure behind it. He also covers Warp going open source, Apple’s Mac supply crunch, OpenAI’s goblin tic, the first 1X humanoid factory in the US, Tesla’s Semi finally hitting mass production, Chinese EVs with movie-projecting headlights, the final GPS III satellite, and a quantum researcher who won 1 Bitcoin. – Want to start a podcast? Its easy to get started! Sign-up at Blubrry – Thinking of buying a Starlink? Use my link to support the show. Subscribe to the Newsletter. Email Ray if you want to get in touch! Like and Follow Geek News Central’s Facebook Page. Support my Show Sponsor: Best Godaddy Promo Codes Get 1Password Full Summary Cochrane opens the show with one of the biggest infrastructure stories of the year. GitHub is buckling under unprecedented agentic load, and the world’s largest code host just had its worst reliability month on record. Furthermore, the broader episode threads a clear pattern: AI demand is reshaping infrastructure, hardware supply, and developer tooling in ways the industry did not see coming. GitHub’s Worst Reliability Month on Record GitHub CTO Vlad Fedorov posted an apology on the company blog this week. He acknowledged the platform’s recent failures and committed to a new priority order: availability first, then capacity, then features. Meanwhile, an April 23 merge queue regression silently produced wrong squash commits across 658 repositories and over 2,000 pull requests. Additionally, an Elasticsearch cluster crashed on April 27 after a botnet attack, and GitHub Actions went down on April 28. Outside reconstructions put April uptime under 85 percent. However, GitHub’s own status page stays in the 99 percent range because it does not count degraded performance as downtime. Cochrane notes that GitHub originally planned a 10x capacity increase and has now revised that to 30x in eight months. Mitchell Hashimoto, GitHub user 1299 since 2008, also announced he is pulling his Ghostty terminal off the platform entirely. Warp Terminal Goes Open Source Under AGPL Warp open-sourced its AI-first terminal client this week under the AGPL license. Their contribution model leans heavily on agents handling code, planning, and testing while humans focus on direction and verification. However, Cochrane pushes back on that framing. He argues the recent GitHub problems show that human approval alone is not enough oversight for agent-driven workflows. Additionally, he notes that the more hands-off developers get, the less they can mentally model their own systems. Apple Caught Flat-Footed by Local AI Demand Tim Cook told Wall Street on the Q2 FY2026 earnings call that Mac mini and Mac Studio supply will be constrained for several months. Both machines turned out to be popular local AI workstations, which Apple did not predict. Consequently, Apple discontinued the 512GB Mac Studio upgrade in early March and raised the 256GB upgrade by $400. Some upgraded configurations now show 4 to 5 month delivery estimates. Cochrane connects the demand spike to the OpenClaw wave and his own recent OpenClaw scare, where his install started making suspicious outbound requests. Furthermore, he is in no rush to lean into local agentic tooling given the constant prompt injection and security issues in the space. OpenAI Explains the Goblin Obsession After GPT-5.1 launched, ChatGPT users noticed the model could not stop saying “goblin.” OpenAI traced the bias to the optional Nerdy personality, which was 2.5 percent of all responses but produced 66.7 percent of all goblin mentions. The reward signal during personality training quietly favored creature metaphors. Then the bias leaked into the rest of the model through later supervised fine-tuning. OpenAI retired Nerdy in March, filtered creature words from training data, and added an explicit Codex system prompt rule: never talk about goblins, gremlins, raccoons, trolls, ogres, or pigeons. Cochrane frames this as the beauty and disaster of pattern matching. Additionally, he notes that LLM behavior is not editable like static code; it can only be patched, and the patches stack up over time. Sponsor: GoDaddy GoDaddy has been sponsoring this show for over twenty years. Economy hosting starts at $6.99/month, WordPress hosting at $12.99/month, and domains at $11.99. Use codes at geeknewscentral.com/godaddy for exclusive deals and to directly support the show. 1X Opens America’s First Vertically Integrated Humanoid Factory Bloomberg reports that 1X Technologies opened a 58,000 square foot humanoid robot factory in Hayward, California. The Norway-founded, OpenAI-backed company is calling it America’s first vertically integrated humanoid factory. Their goal: 10,000 NEO home humanoids in year one, with a 100,000 unit target by end of 2027. Furthermore, the first 10,000 unit allocation reportedly sold out in five days when pre-orders opened in October. NEO sells for $20,000 outright or $499 per month. Cochrane is skeptical that humanoids solve a real problem for the average household. However, he sees genuine potential for elderly and disabled users. Additionally, he flags privacy and data collection concerns about robots that have to perceive everything in your home. Tesla Semi Rolls Off the High-Volume Line Tesla rolled the first Semi off its 1.7 million square foot factory adjacent to Gigafactory Nevada on April 29. The Long Range version delivers 500 miles at $290,000, while the Standard Range hits 325 miles at $260,000. Additionally, the Long Range supports the 1.2 megawatt Megacharger that restores 60 percent of range in about 30 minutes. The factory targets 50,000 trucks per year, though analysts project 5,000 to 15,000 deliveries in 2026. Cochrane opens with a recent personal experience. He saw a semi truck on the freeway with the entire cabin removed from the engine, an unusual failure mode he had never seen before. Furthermore, he questions the actual environmental benefit of electric trucking given grid sourcing and battery mineral concerns. The reveal was 2017, and high-volume production is now nine years after that announcement. Chinese EVs With Headlights That Project Movies Huawei’s XPixel headlight system can now project full-color movies up to 100 inches in front of the car. The technology debuted in full color on the Aito M9 and is rolling out across Stelato S9, Qijing GT7, and Luxeed V9 MPV. Additionally, the same hardware powers real safety features: adaptive driving beam, lane-change path projection, and pedestrian crossing direction signaling. Meanwhile, US regulations only approved adaptive driving beam in February 2022. Pixel-addressable projection systems are not covered by current FMVSS rules at all. Consequently, even if these cars sold in the US, the headlights would have to be downgraded to be street legal. The Final GPS III Satellite Reaches Orbit SpaceX launched GPS III SV-10, the tenth and final GPS III satellite, on a Falcon 9 from Cape Canaveral on April 21. GPS III delivers signals 3 times more accurate and 8 times more resistant to jamming than the previous constellation. It also adds the L1C signal, which interoperates with Galileo, BeiDou, IRNSS, and QZSS, plus M-code military encryption. Up next, GPS IIIF launches start in 2027 with up to 22 satellites deploying through about 2037. IIIF adds laser inter-satellite links and optical reflectors for centimeter-level satellite tracking. Cochrane loves this kind of quiet infrastructure win that powers global economics without anyone noticing it. Researcher Wins 1 Bitcoin for a Quantum Attack on Crypto Independent Italian researcher Giancarlo Lelli won Project Eleven’s 1 Bitcoin Q-Day Prize on April 24. He derived a 15-bit elliptic curve private key from its public key using a variant of Shor’s algorithm on rented cloud quantum hardware. Furthermore, the previous record was 6 bits, set in September 2025 on an IBM 133-qubit machine, so this extends the record by a factor of 512. However, Bitcoin uses 256-bit elliptic curve cryptography, so real wallets are not at risk yet. Additionally, other researchers have pushed back on the result. Their criticism: a 15-bit search space is only 32,767 possibilities, which a laptop can brute-force in milliseconds. Project Eleven defends the milestone as a stepping stone for demonstrating Shor’s algorithm running end-to-end on real quantum hardware. Gemini Now Generates Real Files Google rolled out file generation for the Gemini app. Users can now generate PDFs, Word docs, Excel spreadsheets, Google Workspace files, CSV, LaTeX, plain text, RTF, and Markdown directly from a chat prompt. Additionally, files can be downloaded to device or exported straight to Google Drive. The feature is globally available to all Gemini app users. Google Illuminate Turns Papers Into Podcasts Google Illuminate is the experimental Labs tool that converts academic papers into roughly five-minute two-voice podcast-style audio. Generation takes about 30 seconds, with a 20-per-day cap and a 30-day library. Additionally, transcripts are interactive and clickable for jumping to specific moments. Cochrane likes it as an index for triaging papers but pushes back on using it to replace deep reading. He argues that real technical material like clustering logic needs a real read, not a summary by AI podcasters. Cochrane closes with show housekeeping and a callout to Pocket Casts and True Fans as solid modern podcast apps. Have a great night, and happy June. The post GitHub, Goblins, Ghostty, and GPS III #1863 appeared first on Geek News Central.

Have you seen the headlines about anti-amyloid Alzheimer's drugs showing “no clinically meaningful effect”? If some you love has been diagnosed with Alzheimer's, that kind of headline can feel like a gut punch.But before you fall into the pit of despair — or pin your hopes on the next promising treatment — you need to about this essential tool called the hierarchy of evidence so you know how to interpret the evidence for yourself.In this episode, Amy breaks down the hierarchy of evidence, explains what the latest Cochrane review actually found, and shows you how to separate meaningful science from scary headlines and health influencer hype.What to Listen For00:00 — Why the latest anti-amyloid Alzheimer's drug headlines are so easy to misread 02:35 — The hierarchy of evidence: what it is, why it matters, and how it helps you spot hype 04:50 — Why animal studies can be useful—but should not be treated like proof of what happens in women 07:20 — The difference between correlation and causation, using Chanticleer the rooster as a very memorable example 09:05 — What the “moderate drinking is good for your heart” story teaches us about confounding variables 12:15 — Why GLP-1s and dementia risk are more complicated than the headlines suggest 14:30 — Mechanistic versus clinical evidence, and why something can make sense biologically but still fail in real life 16:10 — The difference between “statistically significant” and “clinically meaningful”—and why that distinction matters for Alzheimer's prevention 20:30 — What the Cochrane review actually found about anti-amyloid Alzheimer's drugs 27:45 — Why removing amyloid is not the same as preserving memory, independence, or quality of life 31:30 — The lifestyle habits that still offer the clearest, most empowering path for Alzheimer's preventionThe big takeaway? Don't let a headline—or an influencer—tell you what the evidence means. The better you understand the hierarchy of evidence, the easier it becomes to stay curious, grounded, and empowered.

Daraxonrasib, a first-in-class oral RAS inhibitor, nearly doubled overall survival versus chemotherapy in previously treated metastatic pancreatic cancer, representing a potentially landmark advance in a historically difficult-to-treat disease. The antibody-drug conjugate datopotamab deruxtecan significantly improved progression-free and overall survival over chemotherapy in first-line triple-negative breast cancer, particularly for patients ineligible for immunotherapy. A Cochrane review of nearly 20,000 patients found anti-amyloid Alzheimer's therapies offer minimal clinically meaningful cognitive benefit while carrying meaningful safety risks, complicating their real-world use.

「挺你所想，與你一起生活的銀行」回饋加碼賺~好康別錯過！ 即日起至2026/8/31完成註冊網路投保會員、預約網路投保提醒並登錄可獲OPENPOINT點數；完成線上投保可抽旅遊金。 透過APP可一次查看保險資訊，線上快速投保。了解更多活動訊息 https://fstry.pse.is/95shwh —— 以上為 Firstory Podcast 廣告 —— 蒼藍鴿使用的保健品牌「藥師健生活」:輸入優惠碼「bluepig」享全品項95折優惠!點我購買▶ https://www.phargoods.com/---⟡ 支持蒼藍鴿產出Podcast ➤ https://open.firstory.me/join/bluepigeon0810⟡ 信箱 ➤ bluepigeonn@gmail.com---【各段重點】00:00 AD00:42 間歇性斷食真的那麼神嗎？減重背後的真相03:32 為什麼「系統性回顧」能降低誤差、提高證據可信度03:57 間歇性斷食 vs 傳統節食法：效果差在哪？06:11 為什麼間歇性斷食能幫助減重08:50 遇到減重停滯期，斷食是好用的工具嗎？13:24 斷食會掉肌肉嗎？如何減少減重時的肌肉流失15:58 重點總結#間歇性斷食 #減重 #減重卡關 #進食時間 #16小時禁食 #8小時進食 #168斷食 #隔日斷食 #細胞自噬 #Cochrane #胰島素阻抗 #熱量赤字 #減肥 #瘦肚子 #減重停滯期 #流失肌肉 #減重方法 #減肥神器---⟡ 更多醫學知識：蒼藍鴿著作 ➤ https://reurl.cc/WA7lpLInstagram ➤ https://reurl.cc/ygvba8Youtube ➤ https://reurl.cc/gm6bb7 Powered by Firstory Hosting

Jamie Hartmann-Boyce and Nicola Lindson discuss emerging evidence in e-cigarette research and interview Dr Xinxin Yang, University of Oxford, UK. Associate Professor Jamie Hartmann-Boyce and Associate Professor Nicola Lindson discuss the new evidence in e-cigarette research and interview Dr Xinxin Yang. Dr Xinxin Yang is a qualitative researcher in the Department of Primary Care Health Sciences, University of Oxford. She is part of the Tobacco Addiction Group within the Centre for Evidence-Based Medicine. Dr Xinxin Yang is a Conversation Analyst on the TRIDENT (Tobacco RIsk reDuction with E-cigarette Nicotine Replacement Therapy) project, which aims to develop and deliver tailored smoking harm reduction interventions for people with serious mental illness in routine mental healthcare. In the April 2026 podcast Xinxin talks to Nicola Lindson about conversation analysis work on the MaSC study (Management of Smoking in Primary Care). In the MaSC study usual care was compared to brief advice and an offer to try an e-cigarette. The numbers of participants who reduced and quit smoking were measured at follow-up. She describes how the findings from MaSC will be used to design a communication guide that will be used to train the clinical professionals to deliver the offer of an e-cigarette for the TRIDENT trial. In TRIDENT consultations between the clinicians delivering the offer of e-cigarettes to patients will then be recorded and analysed with conversation analysis. Xinxin explains how this will provide some of the first real-world evidence on how to deliver smoking reduction intervention effectively for people with serious mental illness. This could prove to be valuable for clinicians and also for the service users. The findings may feed into a larger scale trial to be conducted across the UK. This podcast is a companion to the electronic cigarettes Cochrane living systematic review and Interventions for quitting vaping review and shares the evidence from the monthly searches. Our searches for the EC for smoking cessation review carried out on 1st April 2026 found: 3 linked reports (10.1158/1940-6207.CAPR-25-0244, 10.1016/j.addbeh.2026.108672, 10.64898/2026.03.18.26348637). Our search for our interventions for quitting vaping review carried out on 1st April 2026 found: 1 linked report (10.2196/79667). For further details see our webpage under 'Monthly search findings': https://www.cebm.ox.ac.uk/research/electronic-cigarettes-for-smoking-cessation-cochrane-living-systematic-review-1 For more information on the full Cochrane review of E-cigarettes for smoking cessation updated in November 2025 see: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010216.pub10/full For more information on the full Cochrane review of Interventions for quitting vaping published in November 2025 see: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD016058.pub3/full

In Follow the Water: The Unbelievable True Story of a Teenager's Survival in the Amazon, writer and former middle school teacher Ellen Cochrane tells the remarkable true story of a 17-year-old girl who survived a terrifying plane crash in 1971 in the Amazon rainforest and miraculously navigated her way to safety. The young girl was Read More

In this episode, Ray Cochrane unpacks Anthropic’s Mythos model and the Treasury’s emergency meetings with Wall Street, then digs into Apple’s vibe-coding crackdown and a gaming-anxiety study that hit way too close to home. Also covered: Verge’s solid-state motorcycle, UBTech humanoid robot sales jumping 23-fold, Japan’s first osmotic power plant, Finland’s permanent nuclear waste vault, Ghostty landing in Ubuntu, Cloudflare’s EmDash CMS, and a Claude Code skill that talks like a caveman. – Want to start a podcast? It’s easy to get started! Sign up at Blubrry – Thinking of buying a Starlink? Use my link to support the show. Subscribe to the Newsletter. Email Ray if you want to get in touch! Like and Follow Geek News Central’s Facebook Page. Support my Show Sponsor: Best Godaddy Promo Codes Get 1Password Full Summary Cochrane opens the show by framing Anthropic’s new Mythos model as the AlphaGo moment for cybersecurity. From there, the episode moves through Apple’s pushback against AI-generated apps, a gaming anxiety study with a deeply personal hook, a series of “first to ship” energy and robotics wins out of Finland, China, and Japan, and several developer-tool stories that show how quickly the economics of software are shifting. Mythos, the Detection Ceiling, and Wall Street’s Emergency Response Anthropic’s Mythos model has Wall Street rattled. Operating autonomously, Mythos found and demonstrated the exploitation of a 27-year-old TCP SACK bug in OpenBSD, an operating system famous for being one of the most security-focused on the planet. Per Anthropic’s red team, over 99% of the vulnerabilities Mythos has identified remain unpatched. The researchers’ conclusion is blunt: “the moat in AI cybersecurity is the system, not the model.” The policy response moved fast. On April 7th, Treasury Secretary Bessent and Fed Chair Jerome Powell pulled the CEOs of Goldman Sachs, Citi, Bank of America, and Morgan Stanley into Treasury headquarters on short notice. All four banks are now testing Mythos internally. Treasury CIO Sam Corcos is also seeking direct access. Anthropic is gating distribution through Project Glasswing, a limited-access program with JPMorgan, Apple, Google, Microsoft, and Nvidia. Cochrane comes down firmly behind Anthropic’s gated approach. Because a 5.1-billion-parameter open model can apparently recover the core analysis chain for the OpenBSD flaw, this capability is not locked behind Frontier Compute. He wants the critical infrastructure hardened before the public gets keys. However, he also notes the bigger lesson is about human wisdom: people offloading all their thinking to AI lose out on the wisdom that makes any of these tools genuinely useful. Apple Bans Vibe Coding Apps from the App Store Apple has been quietly pushing back against what people are calling “vibe coding” apps. Replit, Vibecode, and an app called Anything all run AI models on the phone and produce working software that runs inside the host app. Apple cites Guideline 2.5.2, in effect since 2017, which requires apps to be self-contained. Replit and Vibecode had their App Store updates blocked. Anything was pulled in late March, briefly restored on April 3rd, and then pulled the same day again. The forcing function is volume. App Store submissions jumped 84% in a single quarter as vibe coding tools flooded Apple’s review queue with AI-generated apps. Cochrane thinks Apple is justified, given the security issues swirling around the Vibe coding ecosystem. Even a beautiful diamond gets lost in a sea of sand, and that flood is exactly what Apple is trying to manage. The company behind Anything is now pivoting to iMessage, desktop, and Android. Playing Video Games to Win Is Linked to Higher Anxiety Cochrane gets personal on this one. Through high school and his early 20s, he was deeply addicted to League of Legends. His dad teased him about it constantly. In the last few years of that addiction, his body would go ice cold and shake every ranked match before. His partner identified it as a panic attack. The moment that happened, he quit. Today, he no longer shakes. The new study lines up with his experience. Researchers Kayleigh Watters and Mikael Rubin at Palo Alto University analyzed a publicly available database of 13,464 adult gamers, most of whom primarily played League of Legends. Players who game to win show higher generalized anxiety but actually play fewer hours, since performance pressure pushes them out. Players who game to relax show strong links between social anxiety avoidance and more hours played. The study appeared in the Journal of Affective Disorders. The headline framing of “playing to win makes you anxious” misses the point. The real finding is more interesting: gaming for avoidance and gaming for competition are both warning signs, for different reasons. Cochrane notes that the League of Legends community’s toxicity has been a running joke for years, and this study suggests the game’s structure may have been manufacturing the anxiety that fueled it. Sponsor: GoDaddy Economy hosting is $6.99/month, WordPress hosting is $12.99/month, and domains are $11.99. Both hosting plans include a free domain, professional email, and SSL certificate. Go to geeknewscentral.com/godaddy for the best pricing and to directly support this independent show. Verge Motorcycle: World’s First Production All-Solid-State Battery Cochrane filled his tank for $60 today, which made this story land especially hard. His mom has driven electric for years and patiently manages a 90-mile real-world range. The next-generation answer is already shipping. Verge Motorcycles, a Finnish company, is the first production vehicle of any kind with an all-solid-state battery. Their 2026 bikes ship in Q1 with a pack from Donut Lab, another Finnish outfit spun out of Verge. The numbers are bonkers. The pack delivers an energy density of 400 Wh/kg, roughly double that of current Tesla cells. It sustains 100kW charging, hits full charge in about 5 minutes in the lab and 12 minutes on the actual bike, and the long-range version covers 600 kilometers (about 370 miles) per charge. Toyota, QuantumScape, and Samsung SDI have all been telling us that solid-state is coming in 2027 to 2030. A Finnish motorcycle company shipping in Q1 2026 just embarrassed them all. UBTech Humanoid Robot Sales Jump 23-Fold UBTech dropped its 2025 annual earnings on April 1st. Humanoid robot revenue hit 820 million yuan, roughly $119 million USD, up 2,203% from 35.6 million yuan the year before. Unit sales went from 3 robots in 2024 to 1,079 in 2025. Shares jumped 14% on the announcement. The customer list is a real industrial deployment: BYD, Foxconn, Geely, FAW-Volkswagen, and Audi. The flagship is the Walker S2, with UBTech targeting 5,000 units in 2026 and 10,000 in 2027. Cochrane is honest about what this means. He does not think we are heading for an extinction event, but worker displacement is a real concern. The US has no universal income or universal healthcare. The people affected are not white-collar managers. They are everyday line workers who already make the least on the ladder. Work efficiency reportedly doubles when these robots arrive, which is a company-side win, but the humans they replace are not getting half a year of gardening leave to retrain. He invites the listener to take on this one directly. Japan Switches On Asia’s First Osmotic Power Plant In August 2025, Fukuoka’s Seawater Desalination Center quietly opened Asia’s first osmotic power facility. It generates about 880,000 kilowatt-hours per year, enough for roughly 220 homes. It is only the second operational osmotic plant in the world, after Mariager, Denmark, in 2023. Osmotic generation uses a salinity gradient: fresh water on one side of a membrane, salt water on the other, and the pressure difference spins a turbine. The clever part is what Fukuoka does with desalination brine. Instead of regular seawater, the plant uses concentrated brine left over from the desalination process. This amplifies the salt gradient and squeezes more energy out of the same membrane. The result is a closed-loop partnership: the desalination facility produces drinking water and leaves brine behind, the osmotic plant turns the brine into electricity, and that electricity runs the desalination facility. Every desalination plant on Earth produces brine, so if Fukuoka’s co-located model works, the same pattern could be replicated across hundreds of plants worldwide. Japan’s Luna Ring Solar Moon Proposal Goes Viral Again Shimizu Corporation’s Luna Ring concept is making the rounds again. The pitch: a 6,800-mile belt of solar panels around the Moon’s equator, beaming microwave power back to Earth. Project lead Tetsuji Yoshida has long argued that a full ring could eliminate fossil fuel dependence entirely. The proposal first surfaced in 2013, has no funding, no government endorsement, and no concrete cost estimate. Shimizu has not put any active development behind it. Cochrane finds the concept fun every time it resurfaces. However, this would have to be a worldwide effort in the truest sense, with treaties, a new generation of launch economics, and microwave power transmission at a scale nobody has demonstrated. Beaming the power back to Earth has always been one of the biggest practical holdbacks. The Luna Ring is inspirational, but not shipping. Finland’s Onkalo Nuclear Waste Vault Opens Finland’s Onkalo facility is the world’s first permanent deep geologic repository for spent nuclear fuel. Operated by Posiva, the facility is buried about 430 meters down in 1.9-billion-year-old bedrock. It is designed to hold up to 6,500 tons of spent fuel and operate until the 2120s. The construction costs about €1 billion, with operating and closure adding roughly €4 billion more before the program is done. The catch is that radioactivity remains dangerous for hundreds of thousands of years. Edwin Lyman, director of nuclear power safety at the Union of Concerned Scientists, warned that the copper canisters will eventually corrode, with different scientific opinions on how fast. Geologic disposal remains “fraught with uncertainties,” and we have never validated an engineered system across a 100,000-year time frame. The bet is that the rock and copper outlast the radioactivity. Cochrane sees Onkalo as time-buying rather than a final answer. It is more of a bank holding spent fuel while science catches up. He prefers it to Japan’s ongoing approach of releasing tritium-treated water from Fukushima Daiichi into the Pacific, even though the dilution is well below WHO drinking water guidelines. Burying the waste in an insurmountable containment strikes him as the more honest answer to a problem nobody knows how to truly solve. Ghostty Terminal Lands in the Ubuntu Repos Ghostty 1.3.0 is now available in Ubuntu 26.04 LTS’s universe repository. The install is simply `sudo apt install ghostty`, no PPAs, no Snap, no Nix, no building from source. Ghostty was created by Mitchell Hashimoto, co-founder of HashiCorp. It is GPU-accelerated, uses native Swift on macOS and native GTK4 with libadwaita on Linux, and supports tabs, splits, profiles, ligatures, and the Kitty graphics protocol. Cochrane recently caught Hashimoto on a podcast, where he walked through his agentic coding workflow. Ghostty is being actively built using AI harnesses like Claude Code and Codex. Hashimoto told a story in which Codex fixed a six-month-old bug in 45 minutes, for a total API cost of $4.14. Personally, Cochrane uses WezTerm, but he is excited to see Ghostty become more widely available with a native UI rather than Electron. Borgo: Rethinking Go Using Rust Analytics India Magazine profiled Borgo, a programming language by developer Marco Sampellegrini (GitHub: alpacaaa). Borgo is statically typed with Rust-like syntax, but it compiles to Go and uses the Go runtime and garbage collector. It includes sum types (Option and Result), pattern matching, and full compatibility with existing Go packages. Notably, it removes Rust’s borrow checker and lifetimes entirely. Borgo is not new. It first appeared on Hacker News in 2023, with a RustLab talk in 2024. The 2026 angle is a renewed look at it through the lens of AI coding agents, since type-rich languages like Rust have been showing outsized productivity gains. Cochrane is a fan of Rust and stands by the borrow checker, but he enjoys these exploratory languages for what they reveal about what developers actually want. Caveman: A Claude Code Skill That Cuts 65% of Tokens Developer Julius Brussee built a Claude Code skill called Caveman that forces Claude to respond in stripped-down fragments. No articles, no “just,” no “really,” no pleasantries, no hedging. The tagline is “why use many token when few token do trick.” Across 10 real dev tasks, Caveman mode averaged 294 tokens per response, compared to 1,214 in normal mode. That is a 65% drop in output tokens. The project is MIT licensed with three intensity levels: lite, full, and ultra. Cochrane stumbled across the project online and shared it with a classmate who had been complaining about token costs. The classmate now insists that “the caveman is the only way to live.” Cochrane has not made the switch, but the bigger point lands. If a community plugin can cut 65% of tokens without correctness regressions, the labs are shipping verbose-by-default and charging users for the privilege. He suspects verbose output makes models feel more trustworthy, even when the token math says otherwise. Cloudflare Launches EmDash as a WordPress Successor Cloudflare released EmDash on April 9th, an open-source, MIT-licensed, TypeScript-based CMS pitched as the spiritual successor to WordPress. The big flex is that it was built in 60 days using AI coding agents. EmDash runs on Astro 6.0, either on Cloudflare’s edge platform or on a standard Node.js server. The plugin security model uses sandboxed Dynamic Workers with explicit permissions, addressing the architecture flaw that Cloudflare says causes 96% of WordPress vulnerabilities. Cochrane could not resist pointing out the irony of the name. The em dash has become the trademark giveaway that an AI was involved in writing. He has reservations about whether EmDash will succeed. WordPress is extremely hard to unseat, plenty of “WordPress killers” have come and gone, and the ecosystem is twenty-plus years deep. He is curious to see what comes next but not optimistic. Google Open-Sources the DESIGN.md Format Google Labs open-sourced the DESIGN.md format used by Stitch, their AI UI design tool. DESIGN.md is a declarative file capturing a project’s design system, colors, typography, and spacing in a way AI agents can read and apply. Cochrane has tried Stitch personally and finds it impressive at producing web designs. He has also seen DESIGN.md-style files already start appearing in repositories. He sees this kind of file becoming a new paradigm for agentic design, alongside robots.txt and llms.txt. However, he worries about a side effect. If everyone uses the same standardized format and the same AI tools, the web could become a homogeneous set of sites that all look the same. He is enthusiastic about the standardization but hopes designers continue to push for genuinely unique work. A 13-Liter PC With a Water Loop Built Into the Case Geeky Gadgets covered a build by “Visual Thinker”, a 13-liter mini-ITX case with custom SLA-printed water distribution plates built directly into the chassis. Instead of traditional soft tubing, plates channel coolant between the CPU and GPU blocks and are sealed with TPU and silicone molds. The case supports a full-size GPU and an SFX power supply. No thermal benchmarks, parts list, or pricing have been published. It is a one-off you cannot buy. Cochrane sees this as a sign of where PC building has gone in 2026. Modern mid-grade GPUs run nearly every recent game, so raw performance is no longer the differentiator. He likes seeing builders lean into design and craft rather than just stuffing the most powerful parts into a box. He admits he is the traditional type and built his own machine to maximize parts, but the design-first direction is a healthy evolution for the hobby. To close out the show, Cochrane recommends Pocket Casts as a podcast app. He finds it picks up new episodes very quickly. Big thanks to GoDaddy for over twenty years of keeping this show on the air, and a reminder that every promo code use is like writing a check to the show. The post Mythos: Cybersecurity’s AlphaGo Moment #1862 appeared first on Geek News Central.

How can I just be in the sensing of my life and the experiences that I have, rather than having to wrestle and fight those?” – Cindy Murray We are thrilled to have beloved Hoffman teacher and coach, Cindy Murray, as our guest today. Cindy responds to Drew’s question – Why the Process? – sharing a few reasons. Cindy had been very successful in her career as a psychotherapist and educator. After suffering a traumatic brain injury, Cindy was shaken. She’d relied heavily on her intellect in her career for success. How would she move forward now with this brain injury? Cindy also found herself “in a conundrum within.” She’d grown up in a loving home with all her needs met. Her parents didn’t discuss feelings, but they were a beautiful, loving couple. Their marriage was Cindy’s role model for relationships, one that lasted more than 50 years. Then, Cindy fell deeply in love with a woman after being married to a man for about 10 years. Suddenly, she realized she had been living the model her parents taught her, but deep within, she understood this wasn’t who she truly is.  During her time at the Process, Cindy reclaimed her true self. Post-Process, Cindy integrated what she learned and began to trust this new relationship with her Spiritual Self. Now, through her work as a Hoffman Process teacher, she holds space for her students to do the same. Listen in to hear Cindy’s journey to learn how to stop wrestling and fighting so she could come to meet her life as it unfolds. Content Warning: This episode references child sexual abuse and may not be suitable for all audiences. Please use your discretion. Watch and listen to Cindy & Drew: https://youtu.be/-tG6xa3SMos Listen on Apple Podcasts Listen on Spotify More about Cindy Murray: Cindy, doing what she loves Hoffman Process teacher, Cindy Murray, earned a Master of Clinical Social Work from Western Michigan University and is a graduate of the clinical training program in Analytical Psychotherapy from the CG Jung Institute of Chicago. Cindy's own Process was pivotal in her personal growth, leading her on the path of connection and presence. As a Hoffman Process teacher, she believes in helping students to further their own deep connection with themselves and to hold presence within themselves and in the world for those they love. Cindy also teaches in the Social Work Department at Western Michigan University and volunteers for the LoveYourBrain Foundation, which empowers people with brain injury and caregivers to feel more resilient, connected, and able to lead fulfilling lives. Originally from Kalamazoo, Michigan, Cindy currently lives in Cochrane, Alberta, Canada, near the Hoffman Canadian retreat site. She enjoys hiking and skiing in the mountains and swimming in the glacial lakes as often as she can. As mentioned in this episode: Love Your Brain Foundation  

We learn about a new injectable microgel to help reduce bleeding in infants who require surgical care. In a mice model, it reduced bleeding by at least 50%. Ashley Brown, Professor of Biomedical Engineering at North Carolina State University and UNC Chapel Hill tells presenter Claudia Hammond more about this new material her team has designed.Joined by Professor of Global Health and Epidemiology at Boston University in the US, Dr Matthew Fox, Claudia hears about a mystery illness that is being investigated by health officials in Burundi, which has caused five deaths and sickened thirty-five people. So far lab analysis of the illness - which causes fever, vomiting, and diarrhoea - has been negative for Ebola and Marburg viruses, Rift Valley fever, and others.We hear about influential analysis from Cochrane which has concluded that "breakthrough" Alzheimer's drugs are unlikely to benefit patients. Researchers said the impact was "well below" what was needed to make a difference to dementia patients' lives. However, their report has also provoked a vicious backlash from equally esteemed scientists who label it as fundamentally flawed.We're joined by health journalist Katie Silver in Mexico, who brings us the news that the President, Claudia Sheinbaum, has announced the details of a plan to introduce universal healthcare – no mean feat in country of 130 million people.And we hear about an experiment that was done by academics to see if they could trick AI chatbots into believing in an entirely fake disease. Presenter: Claudia Hammond Producer: Jonathan Blackwell

This episode explores what massage and acupuncture can genuinely help with, where the benefits appear to be mostly short term, and where the evidence simply does not support the bigger claims.Massage and acupuncture are widely used, and many people spend real time, money, and hope on them. I walk through an important distinction: feeling better is not the same as changing the underlying problem or speeding healing. A treatment may reduce pain, soreness, anxiety, or tension without actually fixing injured tissue or altering the course of recovery.I also explain why the research can be so tricky to interpret. When massage or acupuncture is compared with no treatment, the results often look encouraging. But when they are compared with a sham treatment, the benefits usually shrink. That matters because even light touch, attention, expectation, and the ritual of care may create real symptom relief on their own. I discuss this challenge using a recent JAMA Network Open review.For massage, the strongest case is short-term symptom relief. I review studies showing benefit after surgery, including improved pain, anxiety, and relaxation in cardiac surgery patients and better perceived comfort after colorectal surgeryBut when massage is studied for neck pain, low back pain, or post-exercise recovery, the picture is much more mixed. It may help soreness or pain in the short term, but it does not clearly improve function, healing, or athletic performance, as seen in reviews on neck pain, low back pain and sports recoveryFor acupuncture, I look at the areas where evidence is more promising and where it is less convincing. A recent review found possible benefit for delayed vomiting during cancer care and a Cochrane review found that acupuncture may help with migraine preventionFor chronic low back pain, acupuncture may help compared with no treatment, but it is not clearly better than sham acupuncture, according to a Cochrane review.  For tennis elbow, the evidence suggests possible short-term pain relief, but not strong proof of lasting benefit or faster recovery, based on this systematic reviewTakeaways: Massage seems most helpful for relaxation, short-term relief, and reducing soreness, but not for clearly accelerating healing. Acupuncture appears to have narrower evidence-based uses, especially migraine prevention and possibly delayed vomiting in cancer care. When claims expand into fixing injuries, correcting structure, boosting immunity, or treating a wide range of unrelated conditions, the evidence becomes much weaker.Send us Fan Mail

Step inside five decades of rock history with lighting legend Howard Ungerleider, the man who’s been designing and directing Rush’s light shows since 1974. Hear how a $75-a-week mailroom gig at American Talent International — where he pulled off a rogue booking of Fleetwood Mac before he was even an agent — turned into a lifetime behind the console. Get the story of Howard landing in Toronto to babysit “a club band called Rush,” sleeping on the floor at the manager’s house with a St. Bernard, freezing his hand to a car door at -40 in Cochrane, Ontario, and later jamming with Neil Peart at his house to Genesis and Supertramp records. Howard also talks designing Roll The Bones (the one Rush tour he couldn’t operate), embedding at See Factor to build custom gear nobody else could get, and how Blue Öyster Cult first put him in front of a laser: the same craft he now brings to Foo Fighters, Tool, and Janet Jackson. Then the conversation turns to the upcoming Rush Fifty Something tour — a four-piece now with Anika Nilles on drums and Loren Gold on keys, freeing Geddy to focus on bass and vocals. Learn why Howard still “plays” the lighting console live with two boards and thousands of touch cues, how robotic spots are quietly changing the craft, and why he and Phish’s Chris Kuroda will be swapping rigs at Madison Square Garden. You’ll also hear the Paul McCartney moment in the Taylor Hawkins tribute dressing room that may have sparked the whole tour, and why Howard insists this is a rejuvenation, a celebration, and proof that no matter the rig, the room, or the era, you’ve gotta ALWAYS BE PERFORMING. Because it’s what we do. Press play and enjoy, folks. 00:00:00 Gig Gab 530 – Monday, April 20th, 2026 April 20th: Pizza Delivery Driver Appreciation Day Guest co-host: Howard Ungerleider 00:02:18 Walked into a NYC office to get a recording contract for his band “You need to learn about this industry before you come knocking on people's doors.” Introduced him to Action Talent (which became American Talent International) 00:06:21 For $75/week delivering coffee and working in the mailroom After a year and a half he got booted from Monmouth University, then became the ATI gopher 00:08:17 Hey, do you want Fleetwood Mac to play here? 00:11:44 Booking agent 00:13:17 Can you fill in for a week as Blue Oyster Cult's tour 00:14:51 Howard and Rush were surprised to have Howard working there “I need ten grand” – “no, you can sleep on the floor instead” 00:18:11 Howard had to show Geddy that New York pizza was better than Toronto pizza 00:19:01 Howard learns about Canadian cold Howard's driving, Geddy's riding shotgun, Neil's reading, Alex is smoking a joint 00:20:42 Geddy says, “get out and take a breath of fresh air” 00:22:05 John Rutsey had opted out of touring, Howard moves to Toronto while they're auditioning drummers “Eventually Neil [Peart] walked in…and that was it.” 00:23:32 Howard and Neil used to jam at Neil's house Genesis and Supertramp 00:24:19 Road life's not so bad 200 gigs a year on the road 00:26:09 Rush took a break, Howard did Queensryche and Tesla Howard designed Roll The Bones, but it's the only tour he couldn't operate 00:27:51 Howard tour-managed and lighting designed and operated every tour up through Presto, after which he dropped tour-managing 00:28:41 Dave realizes he met Howard on the Presto tour 00:31:43 Don't put up with crap 00:32:03 Howard's been doing Rush's lights since 1974 00:33:05 Moving from clubs and theaters to arenas Howard embedded himself into See Factor, the lighting company. Lots of custom gear 00:34:54 SPONSOR: Warby Parker – Right now, buy one prescription pair and get 20% off any additional prescription pairs at https://WarbyParker.com/GIGGAB 00:36:40 SPONSOR: Claude.ai – Ready to tackle bigger problems? Sign up for Claude today, which includes access to Claude Cowork, too, when you visit https://Claude.ai/giggab 00:38:10 Howard first saw lasers with Blue Oyster Cult Dr. David Infante, Blue Oyster Cult's laser operator Howard's lasers on on the road with Foo Fighters, Tool, Janet Jackson and more 00:40:37 RUSH Fifty Something Something completely different than Howard has ever done Other dimensions 00:42:04 Mixing the Juno awards Howard says Neil would approve of Anika. 00:44:51 Hey Howard, surprise! RUSH is going to tour again 00:47:03 Howard did lights for RUSH at Taylor Hawkins tribute 00:48:46 Howard prefers mixing live He “plays” the lighting console live Remote spot locations 00:52:07 RUSH Fifty Something… it's band of FOUR. Geddy is happy… playing less keyboards, more bass and vocal focus 00:54:42 Howard: “I create lighting choreography” This tour is (currently) 2.5 hours (things can change, folks!) “I try to enhance the show with lighting that can trigger your emotions. I approach it as an audience member.” Loren Gold's harmonies sound great 00:58:28 Phish and Rush alternating at Madison Square Garden Chris Kuroda also mixes lights live 01:00:45 Howard's going to 85 dates We're here to create positivity, have a good time…and Neil Peart is smiling down 01:05:25 Brian Worthen on FOH 01:08:30 Gig Gab 530 Outtro Follow Howard Ungerleider Facebook Contact Gig Gab! @GigGabPodcast on Instagram feedback@giggabpodcast.com Sign Up for the Gig Gab Mailing List The post 50 Years of Rush: Howard Ungerleider on Lighting the Lighted Stage – Gig Gab 530 appeared first on Gig Gab.

Croup is a clinical syndrome of upper airway obstruction defined by barking cough, stridor, and hoarseness. Management hinges on severity assessment, universal corticosteroid use, and selective epinephrine. The key clinical task is distinguishing typical croup from high-risk mimics that require urgent airway intervention. Learning Objectives Differentiate croup from other causes of pediatric upper airway obstruction using key historical and physical exam features. Apply a severity-based approach to croup management, including appropriate use of corticosteroids and nebulized epinephrine. Recognize clinical features that suggest alternative or life-threatening diagnoses requiring escalation of care. References Cooke A, Conway S, Griffin L. Croup: Rapid Evidence Review. Am Fam Physician. 2026;113(3):254-258. Gates A, Johnson DW, Klassen TP. Glucocorticoids for Croup in Children. JAMA Pediatr. 2019;173(6):595-596. doi:10.1001/jamapediatrics.2019.0834 Bjornson CL, Klassen TP, Williamson J, et al. A Randomized Trial of a Single Dose of Oral Dexamethasone for Mild Croup. N Engl J Med. 2004;351(13):1306-1313. doi:10.1056/NEJMoa033534 Bjornson CL, Johnson DW. Croup. Lancet. 2008;371(9609):329-339. doi:10.1016/S0140-6736(08)60170-1 Bjornson C, Russell K, Vandermeer B, Klassen TP, Johnson DW. Nebulized Epinephrine for Croup in Children. Cochrane Database Syst Rev. 2013;(10):CD006619. doi:10.1002/14651858.CD006619.pub3 Transcript This transcript was generated using Descript and subsequently reviewed and lightly edited for spelling, grammar, and clarity. Minor inaccuracies may remain, and the audio recording should be considered the definitive version of this content.  Welcome to PEM Currents: The Pediatric Emergency Medicine Podcast. As always, I'm your host, Brad Sobolewski. And today we're gonna talk about croup. We're gonna focus on diagnosis, severity based management, and how to differentiate it from scarier high risk conditions that may present similarly, but behave very differently. So croup is best understood as a clinical syndrome of upper airway obstruction caused by inflammation at the level of the larynx and subglottis. So in most cases this is viral laryngotracheitis, most commonly due to parainfluenza virus. But as you'd expect multiple viruses can cause it. The subglottis is the narrowest portion of the pediatric airway. So even small amounts of edema create large increases in airway resistance. So that's why the clinical picture is so consistent. You've got inspiratory stridor, hoarseness, and that characteristic barking cough, which either sounds like a seal or a dog, and yes, of course, I know the difference between the two coughs because I was a biology major. This is primarily a disease of children between six months and three years of age with a peak incidence in the second year of life. It's really, really common, like one and a half percent of all ED visits, maybe 350,000 visits a year, and 85% of these kids have mild disease. Hospitalization is rare. The range is variable, about two to 8% of cases, and return visits occur in about three to 5%. Fewer than 1% of children, a lot fewer, require intensive care or airway intervention. Honestly, most kids do really well. The ones who don't can get sick very quickly, and that's been my clinical experience. In the Northern Hemisphere, we see croup throughout the fall and winter, usually starting in around November and sort of tapering off by April. But that being said, I've seen croup-like symptoms every month of the year over the past couple of decades. Croup is absolutely a classic clinical diagnosis. A typical case begins with 12 to 48 hours of viral prodrome, you know, body aches, fever, congestion, cough, followed by often abrupt nighttime onset of barky cough and stridor. Symptoms fluctuate, and they're generally worse with agitation and get better when the kid is calm. That variability is the key feature. So what you'll have is a child who wakes up after sleeping for a few hours with a barky cough and then noisy stridor. This freaks parents out, and this is not hyperbole. There's this little center in the back of your brain that's like, please don't stop breathing and die. So appropriately, they're worried about the kid, they call emergency medical services, they bring them to the emergency department, and by and large, by the time they get there, the stridor has resolved. The kid is calm, and parents will say, I swear he looked a lot worse at home. Trust me, we believe you parents, this is what croup does. When I'm taking a history of croup, I get all of these details. Are there any sick contacts? If the parents are worried about a foreign body inhalation or ingestion, then I'm worried about a foreign body inhalation or ingestion. Listen to the lungs, inspect their airway. Always check the ears for concomitant otitis and I'll feel their trachea. I'll actually grab and hold the trachea and move it. Kids with croup really don't have a painful trachea. Kids with bacterial tracheitis, aside from looking more toxic, actually have a lot of pain when they move their trachea. Testing for croup is generally unnecessary. Labs and viral studies do not change management, and imaging is really reserved for atypical presentations or when you're considering an alternative diagnosis like a foreign body. If you do get an X-ray, what you're looking for is the classic steeple sign on the AP view. It is seen in croup, but it's not 100% sensitive nor specific. Once you've made the diagnosis of croup, it's important to assess severity, and remember that I said that most kids are mild. So mild croup is defined by the absence of stridor at rest. So they may have some stridor when they're upset or even a little bit of hoarseness or noise. It's important to listen to many, many children with croup to get a sense of this. Moderate croup includes stridor at rest with mild to moderate retractions. So at rest means that the child is in a position of comfort. They're calm with a parent, and they've generally been that way for about 10 to 15 minutes. Sometimes that's how long it can take for the stridor to dissipate once you get the kid calm. Severe croup, which is fortunately rare, involves marked work of breathing, agitation, fatigue, need for oxygen, altered mental status, and this aligns with the Westley croup score. It formalizes stridor, retractions, air entry, cyanosis, and mental status. But really, in practice, most of us get very good at bedside assessment of croup. Management of croup starts with corticosteroids. This is one of the highest-yield interventions that we have in pediatric emergency medicine. Every child with croup should receive dexamethasone. Typically 0.6 milligram per kilogram as a single dose up to a maximum of 10 milligrams. Some places will use 0.15 milligram per kilogram. Locally, we often give the IV formulation orally. It's 10 milligrams per mL. Tastes bad, but pairs reasonably well with apple juice. The oral suspension is 1 milligram per mL, tastes terrible, and pairs nicely with being spit on the ground by toddlers. The evidence behind dexamethasone is very robust. The main benefit is that it reduces return visits and hospital readmissions by about half, and those return visits include doctor's offices and emergency departments. In a Cochrane review of 1,679 children, glucocorticoids reduce return visits or readmissions with a risk ratio of 0.52, so that translates to a number needed to treat of seven. I've certainly seen seven or more croup kids during one shift, so for every seven children treated with dexamethasone, one return visit is prevented. Symptom improvement begins within about two hours and lasts at least 24 hours, but maybe up to a couple of days. Hospital length of stay for kids that get steroids is reduced by an average of 15 hours as well. Serious adverse events are rare. It's well tolerated, and other than the taste, kids do fine with it. And importantly, the benefit is consistent across all severities of croup, mild, moderate, and severe. So when you explain this to families who are very scared about their kids, but now their kid is looking better and you're only giving them a single medicine, not doing any tests or X-rays or anything, I think you have to frame the medicine in terms of what it's going to do for them over the next couple of days. So one way of explaining this to families would be to say something like this is a steroid called dexamethasone. It reduces the swelling in your child's airway that's causing the barky cough and noisy breathing. Most children start feeling better within a couple of hours, and the benefit lasts at least a full day, if not longer. Without this medicine, about one in five children need to come back because symptoms get worse again. You really get two bad days with croup in most cases. With this medicine, the risk of returning drops to about one in 10, so it cuts the chance of coming back in half. We can expect your child's cough to start improving over the next day or two. Most children are feeling a lot better within 48 hours, though a little bit of hoarseness and cough can last for a week to about 10 days. So it's possible that when your child goes to sleep later tonight, they may experience that barking cough and noisy breathing again. They're almost certainly going to be upset. The steroid blunts enough of the swelling so that you are much more likely to have them free of distress and stridor, that noisy breathing, once you get them calm. So if they're upset, get them calm, and if in about 10 minutes the stridor and noisy breathing get better, that's the dexamethasone doing its job and you can safely stay home. For children with moderate or severe croup, we're gonna use nebulized racemic epinephrine. It works fast by reducing airway edema by constricting inflamed blood vessels. You'll see improvement in stridor and work of breathing often within 30 minutes. The effect is transient and largely gone by about two hours, and you need to do a structured reassessment at about 30 minutes after the racemic epinephrine. If the child's clearly better, continue that observation for up to two hours. If they're unchanged or worse, repeat the epinephrine and start thinking more carefully about your diagnosis and disposition. Because it's got such a short duration, that two hours after treatment is the most common time period, though some institutions and some children will need to be observed a little bit longer. If they remain well appearing with no stridor at rest, normal oxygenation, minimal work of breathing, and they can tolerate oral fluids, they can be discharged. If symptoms recur, they require repeated epinephrine, or they fail to improve, then you may have to escalate care and consider admission. Honestly, with croup, supportive care is still one of the most important things. You gotta keep kids calm by minimizing agitation. Parents are experts at this with their own children. Agitation worsens airway obstruction. Airway resistance is fourfold greater when the kid's upset. Give oxygen if the kid's hypoxic. Fortunately, this is rare. Antipyretics and fluids are great, do them. Humidified air has not been shown to provide meaningful benefit, and obviously we should avoid sedatives because they can suppress respiratory drive without improving airway patency. Many parents will say that their kid was better when they were exposed to cool air or mist in the shower. Those can help, but honestly, don't stick your kid's head in the freezer if it upsets them. Keep them calm, hold them, and comfort them. Alright, croup, barking cough, stridor, variable symptoms, easy, right? There are some other diagnoses that can mimic this or overlap that you shouldn't miss. Spasmodic croup is a related phenotype. You've got sudden nighttime onset, often minimal prodrome, and recurrent episodes. These kids are typically well between episodes, and the pattern becomes more apparent over time. Some kids will bark with every mild cold or stuffy nose up until about eight or nine, but they usually don't have stridor and respiratory distress. Bacterial tracheitis is progression to a more severe and dangerous airway infection. These children often start with viral symptoms and then rapidly worsen. They've got a high fever, they appear toxic. Most importantly, they fail to respond to standard croup therapy. Toxic appearance plus lack of response should immediately shift your diagnostic reasoning. These kids may have a lot of pain when you grab and move their trachea. The cough can be more junky because again, they've got purulent mucus in their trachea. Epiglottitis is defined by the absence of barking cough and the presence of drooling, dysphagia, and tripod positioning. These children are very anxious, they're very ill, their airway is at risk, and so your immediate priority is keeping them calm and having the airway managed in the safest environment, generally the operating room. Deep neck space infections, including retropharyngeal cellulitis and abscesses and peritonsillar abscesses, present with fever, neck stiffness, sometimes even torticollis, and lymphadenopathy. Kids won't really have a barky cough and the exam localizes to the neck rather than the airway alone. Acute foreign body aspiration presents with sudden onset symptoms, no viral prodrome, no barking cough, and sometimes some asymmetric exam findings. The diagnosis is frequently missed when clinicians anchor too early on croup. If you have an esophageal foreign body, remember that 70% of these get stuck at the thoracic inlet. So always think about a kid who sounded like they had croup and got croup treatments, but also has some swallowing issues and is the right age to put things in their mouth. This is when you see coins and button batteries and other things stuck not in the upper airway, but in the esophagus right behind it. Alright, now when it comes to disposition, most kids with croup are gonna be sent home. Children who improve, they have no stridor at rest, minimal work of breathing, can be discharged home with clear return precautions. Those with persistent symptoms, need for repeated racemic epinephrine, hypoxia, or concerning features should be admitted. For kids who continue to worsen despite standard therapy, escalation includes high-flow nasal cannula, noninvasive ventilation as a bridge. Heliox can be used as a temporizing measure to reduce work of breathing. Fortunately, needing to intubate a child with croup is rare, but when it's needed, it can be challenging due to subglottic narrowing. You need the best proceduralists, and you should downsize your endotracheal tube by 0.5 to 1 millimeter smaller than usual. And I'll reiterate this again. The natural course of croup is really favorable for most kids. The fear's not gonna go away for the parents, this is a scary diagnosis, but I think with some reassurance, we can help them understand that this is something that is unlikely to cause significant problems and will get better. Most kids improve significantly within 48 hours, though like any other respiratory illness, symptoms can persist for a week or so. Severe outcomes are fortunately rare, and they almost always occur in children whose severity or alternative diagnosis was not recognized early. So again, here's my take-home points. Croup is a clinical diagnosis. Severity determines your management. Steroids, dexamethasone, should be given to all patients. Racemic epinephrine is used for moderate to severe disease with mandatory reassessment and observation. And most importantly, always reassess the diagnosis when the presentation does not fit the expected patterns. Things can get rough when you're barking up the wrong tree and thinking it's croup when it's actually something else. Well, I hope you enjoyed this episode on honestly one of the most classic conditions that we see in the pediatric emergency department. If you've got any feedback on the episode, send it my way. As the kids would say, like, rate, and review. I would love it if you left a review on your favorite podcast site. It helps more people find the show. I do this as a labor of love because I enjoy teaching, and I think that this is a wonderful way to reach my colleagues and learners. If you've got suggestions on other topics or episodes, I'd love to hear them. For PEM Currents: The Pediatric Emergency Medicine Podcast, this has been Brad Sobolewski. See you next time.

Send us Fan MailFollow the Water by Ellen CochraneWhen Juliane is 17 years old, she falls out of an airplane almost 2 miles up...and survives! What makes this an even more amazing story, is she is able to survive her days and nights in the Amazon jungle for nearly two weeks, using all the knowledge she has learned from her parents and her time living at their scientific station as she grew up. But even with all of that information, survival will not be easy, or guaranteed.Recommended for grades  7 and up.Support the show

Pope Leo XIV's first Easter message, where he called for global peace amidst conflicts like the Russia-Ukraine war and the US-Israeli war on Iran. The "messy" irony lies in the transition from a solemn papal address on world "ravaged by wars" to the interpersonal "messiness" and psychological pathology discussed in the following segments.   The Anti-Inflammatory Power of Basil Basil contains a high concentration of Eugenol. In the world of natural chemistry, Eugenol is a "blocker"—it actually works similarly to over-the-counter NSAIDs (like Ibuprofen) by inhibiting the enzymes (COX-2) that cause swelling and pain in the joint. How it adds to your Aloe-Herb Salve: Adding Basil creates a "Triple Threat" for your severe arthritis: Rosemary: Increases local circulation (brings blood flow to the joint). Lemon Balm: Calms the "angry" sensory nerves around the kneecap. Basil: Acts as the heavy-duty anti-inflammatory to reduce the actual swelling. Savoring the Silence & Protecting the Peace. You can't fix stupid, and you certainly can't fix a narcissist. But you can fix your boundaries. If every time you share a win, you get a grunt, stop sharing the win. Build your 'Silent Resort' and invite people who know how to celebrate. Your joy is too expensive to be spent on someone who is committed to being miserable. Protect that peace! Federation is a hard sci-fi crossover; it functions as a secular Passion play. It tells the story of a man (Cochrane) who suffers through a global apocalypse (WWIII), offers humanity "salvation" through the light of warp drive, disappears (dies to the world), and is ultimately "resurrected" through the grace of an alien entity and the legacy he leaves behind. The Bravo-verse: A Masterclass in Internalized Bias & Bozoma St. John, Gamer Recognized Game. I don't think I am kissing up, I am calling a spade a spade. And Boz St. John is calling 4-a possible- 5, yelling Domino, Uno Reverse-draw 4-Uno on those b@@@chs.      Just when I thought I was going to leave Reality TV commentary to the pros, here comes Ciara Miller and The Boz of it all....While the underfed hippos are snapping in the fake LA swamp, Bozoma is playing the Kobayashi Maru of the C-Suite. She didn't come to win the game; she came to audit the players and then unplug the board. Checkmate. Meeting Adjourned.   Check out my music on Spotify and Apple or wherever you listen to music! The official videos are on YouTube. Stream and stream often! Navigate to https://linktr.ee/tnfroisreading to check out all coffee and book options. Seasonal Affective Disorder Is Treatable and all of us should be about fixing our mental health always.... If you are searching for help and direction in your struggles with depression and addiction Call 1-800-273-8255 Available 24 hours everyday   There is also an online chat feature https://suicidepreventionlifeline.org/chat/   And if Vodka is the problem, call  1-800-662-HELP (4357) for 24/7 help. Please reach out to find joy in this season!

SHOW SCHEDULE JOHN BATCHELOR SHOW, 4-1-2026.1602 DUTCH REPUBLIC1. HEADLINE: China's Strategic Role in Global and Middle Eastern Conflicts GUEST: Victoria Coates, Gordon Chang SUMMARY: Experts discuss China's strategic presence in global conflicts, including its reliance on Gulf oil and support for Russia. They analyze China's limited effectiveness as a mediator between the U.S. and Iran. (1)2. HEADLINE: Naval Lessons from the Strait of Hormuz for Taiwan's Defense GUEST: Jim Holmes, Gordon Chang SUMMARY: Professor Jim Holmes applies naval lessons from the Iran war to a potential Taiwan conflict. He emphasizes using geography for defense, prolonging wars to assemble forces, and utilizing low-cost drone technology. (2)3. HEADLINE: Investigating Subversive Chinese Influence and Funding in America GUEST: Charles Burton, Gordon Chang SUMMARY: Charles Burton discusses billionaire Neville Roy Singum's alleged role in funding radical organizations to subvert Western democracy. The discussion highlights China's use of social media algorithms and direct donations to influence youth. (3)4. HEADLINE: Concerns Over U.S.-China Trade Talks and Forced Labor Enforcement GUEST: Charles Burton, Gordon Chang SUMMARY: Analysts express skepticism regarding upcoming trade negotiations between President Trump and Xi Jinping. They also criticize Canada's failure to effectively block Chinese products manufactured using forced labor in Xinjiang. (4)5. HEADLINE: National Security Implications of the Chinese Humanoid Robotics Industry GUEST: Jack Bernham SUMMARY: Jack Bernham explores China's burgeoning humanoid robotics industry and its potential military applications. U.S. senators are moving to block Chinese robots from federal supply chains to prevent security vulnerabilities. (5)6. HEADLINE: Smuggling Operations Evading U.S. AI Chip Export Controls GUEST: Jack Bernham SUMMARY: An indictment reveals a massive operation smuggling $2.5 billion in Nvidia chips to China via Southeast Asia. Experts suggest closing loopholes that allow Chinese firms to purchase chips domestically. (6)7. HEADLINE: Turkey's Diplomatic Strategy as a Mediator in the Iran War GUEST: Sinan Ciddi SUMMARY: President Erdogan seeks to mediate a ceasefire in the Gulf to protect Turkey's weak economy from rising oil prices. However, he also benefits from a weakened Iranian regime countering Israel. (7)8. HEADLINE: Turkey's Patronage of Hamas and Regional Security Concerns GUEST: Sinan Ciddi SUMMARY: Turkey maintains close ties with Hamas leadership, viewing them as a legitimate political movement rather than terrorists. Rumors also suggest Turkey may be aiding the flow of supplies to Hezbollah. (8)9. HEADLINE: European Energy Dependency and the Shift Toward Russia GUEST: Michael Bernstam SUMMARY: Rising energy costs are driving political shifts in Germany and other EU nations toward re-engaging with Russian energy. Despite EU sanctions, Russia is profiting from increased oil prices during the Iran war. (9)10. HEADLINE: Russia's Struggling Economy Amid Prolonged War and Sanctions GUEST: Michael Bernstam SUMMARY: Russia faces a looming recession, high inflation, and a structural contraction due to reduced investment. The government has nationalized private pension funds to finance the war effort and infrastructure projects. (10)11. HEADLINE: The Impact of War and Oil Shocks on Global Interest Rates GUEST: John Cochrane SUMMARY: Professor John Cochrane explains how oil shocks and inflation fears drive up long-term bond rates. He warns that bad policy responses, like price caps, can turn price shocks into sustained inflation. (11)12. HEADLINE: Federal Reserve Policy and the Risks of Stagflation GUEST: John Cochrane SUMMARY: The Federal Reserve is adopting a "wait and see" approach to the current oil shock. Cochrane warns against repeating 1970s mistakes, such as credit controls or failing to act decisively against inflation. (12)13. HEADLINE: NASA's Artemis 2 Mission and the New Lunar Frontier GUEST: Douglas Messier, David Livingston SUMMARY: Douglas Messier details the upcoming Artemis 2 mission, the first crewed flight to the moon since 1972. The 10-day mission will test the Orion spacecraft's life support and technical systems. (13)14. HEADLINE: International Competition for a Permanent Base on the Moon GUEST: Douglas Messier, David Livingston SUMMARY: NASA plans to establish a permanent lunar base by 2036, facing competition from a joint Chinese-Russian program. Success relies on commercial landers from SpaceX and Blue Origin to reach the South Pole. (14)15. HEADLINE: Re-examining Russian Interference in the 2016 U.S. Election GUEST: Craig Unger SUMMARY: Journalist Craig Unger reviews the events of October 7, 2016, involving DHS warnings of Russian hacking and the release of the Access Hollywood tape. He argues the timing benefited the Trump campaign. (15)16. HEADLINE: Alleged Long-Term Financial Ties Between Trump and Russian Intelligence GUEST: Craig Unger SUMMARY: Craig Unger discusses alleged ties between Donald Trump and Russian intelligence dating back to the 1980s. He claims the Russian mafia used Trump real estate for money laundering to bail out his businesses. (16)

12. HEADLINE: Federal Reserve Policy and the Risks of Stagflation GUEST: John Cochrane SUMMARY: The Federal Reserve is adopting a "wait and see" approach to the current oil shock. Cochrane warns against repeating 1970s mistakes, such as credit controls or failing to act decisively against inflation. (12)1935 KHURMA KARIN

In this episode, Ray Cochrane digs into a new study showing AI is literally frying workers’ brains, then unpacks Anthropic’s wildest month ever – from a 1,487% user surge to Pentagon retaliation to a leaked model called Mythos. Also covered: OpenAI kills Sora after burning $15 million a day, OpenClaw’s terrifying security holes, Apple axing the Mac Pro, ARM’s first-ever production CPU, and why King Tut’s dagger was forged from a meteorite. – Want to start a podcast? It’s easy to get started! Sign-up at Blubrry – Thinking of buying a Starlink? Use my link to support the show. Subscribe to the Newsletter. Email Ray if you want to get in touch! Like and Follow Geek News Central’s Facebook Page. Support my Show Sponsor: Best Godaddy Promo Codes Get 1Password Full Summary Cochrane opens the show with a study that puts a name to something most AI-heavy workers have already felt. From there, the episode moves through one of the most turbulent months in AI industry history, touching on corporate ethics, national security, hardware shortages, and ancient archaeology. AI Use at Work Is Causing “Brain Fry” A study from Boston Consulting Group and UC Riverside surveyed 1,500 full-time US workers and found that 14% experience what researchers call “AI brain fry” – mental fatigue from excessive AI tool oversight. Those affected report 33% more decision fatigue, 39% more major errors, and an increase in intent to quit from 25% to 34%. Notably, productivity peaks at one to three AI tools and drops off at four or more. Cochrane relates this directly to his own workflow, often running two to four tools side by side. However, he pushes back on the doom framing. He argues that context switching across multiple projects and rubber-stamping AI output without review are the real sources of fry. His takeaway: either work more slowly with greater intent, or use the accelerated pace to reclaim free time. Anthropic’s Wild Month: Exodus, Pentagon, and Mythos Claude sessions surged by roughly 1,487% from mid-January to early March, knocking ChatGPT off the top spot in the app store for the first time. ChatGPT uninstalls spiked nearly 300%, one-star reviews exploded 775% in a single day, and a boycott movement called “Quit GPT” has grown to between 2.5 and 4 million participants. The catalyst was OpenAI stepping in to take the Pentagon defense deal that Anthropic had publicly declined. Cochrane is firmly against automated domestic surveillance and autonomous weaponry, noting that the models are not reliable enough for such responsibilities. OpenAI tried to walk it back, but the Electronic Frontier Foundation called their language “weasel words.” Meanwhile, the Department of Defense slapped Anthropic with a supply chain risk label – a national security designation previously reserved for hostile foreign companies. Anthropic sued the Trump administration. Then Microsoft filed a legal brief in Anthropic’s defense, joined by 149 former judges, dozens of Google and OpenAI employees, and nearly two dozen retired generals. On top of all that, security researchers discovered an unsecured data cache exposing nearly 3,000 unpublished Anthropic files, including a model code-named Mythos (also called Capybara). Internal documents describe it as a step change in capabilities, scoring dramatically higher than Opus 4.6 on coding, reasoning, and cybersecurity. Then Anthropic’s source code leaked publicly as well. Sponsor: GoDaddy Economy hosting is $6.99/month, WordPress hosting is $12.99/month, and domains are $11.99. Both hosting plans include a free domain, professional email, and SSL certificate. Go to geeknewscentral.com/godaddy for the best pricing and to directly support this independent show. OpenAI Shuts Down Sora Video App OpenAI announced on March 24th that it is killing Sora, its AI video-generation app. Downloads cratered from 3.3 million in November to 1.1 million by February. The real numbers are brutal: Sora was costing roughly $15 million per day to run against a total lifetime revenue of just $2.1 million. The Sora web and app experience ends April 26th, with the API shutting down September 24th. Additionally, the Disney partnership – a billion-dollar deal meant to validate AI in Hollywood – collapsed completely. Deep fakes of Martin Luther King Jr. and Robin Williams appeared almost immediately despite guardrails, and both families protested publicly. Cochrane notes that competitors like Runway, Pika, and Kling are still operating, and suspects Hollywood will pivot to generating scene backgrounds rather than full content. OpenClaw Is a Security Nightmare Cochrane’s personal OpenClaw install started making outbound requests flagged by his ISP – with no changes or new skills installed. He shut it down and plans to wipe the device entirely. The broader picture is alarming. A January 2026 audit found 512 vulnerabilities in OpenClaw, eight critical. Twenty-six percent of community skills contain at least one vulnerability. Oasis Security discovered a vulnerability chain called “Clawjacked” where any website can silently take full control of a developer’s agent. Between March 18th and 21st alone, nine additional vulnerabilities were disclosed, several of which were rated 9.9 out of 10. Cochrane draws a direct parallel to the browser extension era: supply chain attacks hidden as helpful tools. Claude Code Auto Mode: AI Policing AI Anthropic published details on a new “auto mode” for Claude Code after finding that users approve 93% of permission prompts – essentially mashing “yes.” Auto mode replaces manual approvals with a two-layer defense: an input scanner to detect prompt injection and a second AI model that monitors the first and decides whether to allow each action. The safety checker can only see what the user asked for and what the AI is trying to do. It cannot see the AI’s reasoning, so the AI cannot talk its way past the check. However, Cochrane notes it still misses about one in six dangerous actions (17%), and the fundamental question remains: if the base layer can get infected, so can the checker. Qwen Overtakes Llama as Most-Deployed Self-Hosted LLM RunPod’s 2026 State of AI report, based on usage data from 183 countries, reveals that Alibaba’s Qwen has overtaken Meta’s Llama as the most popular self-hosted AI model. Llama 4 has barely been adopted, with users sticking to version 3 because it just works. Additionally, vLLM now powers 40% of all AI endpoints, NVIDIA’s latest GPU usage scaled 25x last year, and nearly 70% of AI image work runs through ComfyUI. Cochrane sees Qwen winning on merit and argues that is how open source should work. AI Data Centers Are Taking All the CPUs Too AI data centers are not just consuming GPUs and memory anymore – CPUs are now being strained too. Intel server CPU lead times have stretched from two weeks to six months. AMD typically occurs at 8 to 10 weeks. Server CPU demand is projected to jump 15% in 2026, but Intel’s output capacity is growing in single digits. The shift from chatbots to autonomous AI agents is changing the hardware ratio, since agents require far more CPU power to coordinate tasks and call tools. TSMC is prioritizing more profitable AI chips over regular CPUs. Cochrane warns that consumers and businesses are effectively subsidizing the AI boom through higher prices and longer waits. AMD Ryzen 9 9950X3D2: First Dual-Cache X3D CPU AMD announced the Ryzen 9 9950X3D2, the first CPU with dual-cache X3D technology. It arrives April 22nd with 208MB of total cache and a 200W TDP – up from the current model. However, AMD is unusually honest, calling the gains “modest,” ranging from 5-13% depending on the workload. Notably, they have not released gaming benchmarks, which is conspicuous for an X3D chip. Cochrane owns a single X3D chip and sees no reason to upgrade. ARM Launches “AGI” CPU After 35 years of licensing chip designs to Apple, Qualcomm, Samsung, and NVIDIA, ARM has launched its first production silicon: a 136-core server chip co-developed with Meta as the lead customer. ARM’s stock jumped about 16% on the news. You can pack over 8,000 cores in a single air-cooled rack, or over 45,000 with liquid cooling. Volume shipments begin by the end of 2026. Cochrane appreciates the move but calls the “AGI” branding marketing hype. The bigger story is ARM transitioning from blueprint designer to direct competitor against Intel, AMD, and NVIDIA in data centers – while still licensing to the companies it now competes against. Apple Discontinues the Mac Pro Apple removed the Mac Pro from its website and confirmed that no future model is planned. The $6,999 machine had not been updated since the 2023 M2 Ultra model. Apple is pointing professionals toward the Mac Studio with its M4 Ultra chip, with an M5 Ultra refresh expected later this year. They also discontinued the $700 wheels kit, $300 feet kit, and Pro Display XDR the same week. Cochrane says good riddance – the Mac Studio covers what 90% of users need. Apple’s AI Pin: An AirTag-Sized Wearable Reports suggest Apple is developing an AirTag-sized wearable AI pin with cameras, microphones, and wireless charging. It would clip to clothing or hang as a necklace, running as an iPhone accessory powered by an upgraded Siri with Google’s Gemini AI. A possible 2027 release is expected alongside iOS 27, though development is early and could be canceled. Cochrane ties this to a broader shift: data collection moving from the application layer to physical devices. Apple employees internally refer to the device as “the eyes and ears of the iPhone.” He warns that always-on wearable cameras, combined with existing AI-powered surveillance poles, are pushing society deeper into mass data collection without meaningful consent. Quantum Entanglement Speed Measured for the First Time Scientists at TU Wien’s Institute of Theoretical Physics, led by Professor Joachim Burgdorfer, measured how fast quantum entanglement happens for the first time. The answer: about 232 attoseconds – a billionth of a billionth of a second. The research was published in Physical Review Letters in late 2024 and is now circulating widely. Einstein called quantum entanglement “spooky action at a distance.” Turns out it is not instantaneous – just extraordinarily fast. This measurement technique opens the door to quantum cryptography and quantum computing. However, Cochrane clarifies: this does not mean faster-than-light communication. Entanglement links particles but does not transmit information through space. Bronze Age Iron Artifacts Came From Outer Space Geochemical analysis by French scientist Albert Jambon, originally published in the Journal of Archaeological Science in 2017, confirmed that virtually all Bronze Age iron artifacts were made from meteorites. The artifacts span Egypt, Turkey, Syria, and China, including beads dating to 3200 BCE and the famous dagger from King Tut’s tomb, dating to around 1350 BCE. The story resurfaced after researchers published new findings this month on fragments of meteoritic iron weapons from China’s Sanxingdui sacrificial site. Bronze Age people lacked the technology to smelt iron ore, but meteoritic iron arrived in a metallic state, ready to be forged. Cochrane closes the episode, noting that ancient civilizations were working with extraterrestrial material before they could produce their own iron – resourcefulness that deserves respect. Cochrane wraps up the show by thanking GoDaddy for over twenty years of partnership and reminding listeners to subscribe, sign up for the newsletter, and reach out via email. The post Agentically Frying your Brain using AI #1861 appeared first on Geek News Central.

(2412 E Cochrane Rd): https://creepypasta.fandom.com/wiki/2412_E_Cochran_Rd   Intro/Outro music: Ghost Story by Kevin MacLeod Link: https://incompetech.filmmusic.io/song/3805-ghost-story  License: https://filmmusic.io/standard-license  Thumbs up to all our listeners, the community of Creepypasta Fandom wiki and the stories creator/poster:MmPratt99. Without, we wouldn't have this discussion. So thank you all! (Mmpratt99): https://creepypasta.fandom.com/wiki/User:Mmpratt99_deviantart  (Creepypasta.wiki): https://creepypasta.fandom.com/wiki/Creepypasta_Wiki  Comment below or send us an email at aldenterigamortis@gmail.com    Also check out the title cards for each episode: http://crazonstudios.tumblr.com/  And if you want to show your support, consider becoming a Patron: https://www.patreon.com/aldenterigamortis

The recording for this Talking in Carz episode starts a few minutes into the show, but once it kicks in, DJz and Jules go deep on Arcfall launch day, the new Borg Sphere loop, and the real math behind blueprint acquisition in Star Trek Fleet Command. This episode breaks down how the new hostile mechanics work, why killing hostiles without the Sphere does not really help progression, and how the Sphere's tasks and Maverick-credit rewards are designed to scale over time. DJz and Jules also tackle the biggest hot-button topic of the launch: blueprint cost, free-to-play timelines, and the hard choices players now have to make between Dive Bar upgrades, research, officers, and Sphere progress. They also cover Suppressors vs. Obliterators, forbidden tech, Chaos Tech, new refits, artifacts, epic Maverick credits, and why the Sphere is best understood as a loop-focused ship rather than an all-purpose monster. Along the way, they share the strategy advice players need most on day one, including when to prioritize Dive Bar 20, when Dive Bar 30 may actually be smarter, and why Jules' calculator is so important for planning your path. If you're trying to figure out whether the Borg Sphere is worth chasing, how long free-to-play acquisition may really take, and what matters most in Arcfall right now, this episode is your roadmap. #StarTrekFleetCommand #STFC #Arcfall #BorgSphere #TalkingTrek #TalkingInCarz #Scopely #STFCStrategy #MaverickFaction #StarTrek   00:00 First Contact event hype and exclusive real-life rewards 00:01:04 Recording picks up mid-show and the informal live-only format begins 00:01:34 Can players kill new hostiles without the Sphere? 00:02:55 Burning vs. hypothermic decay and the round-one kill loophole 00:04:07 Suppressors vs. Obliterators and early punch-up possibilities 00:04:42 The blueprint-cost debate and why players will have to choose 00:06:18 Best early priorities: Dive Bar 20, key research, then blueprints 00:08:15 How long it should take newer Ops 55 players to reach Dive Bar 20 00:09:05 Punch-down strategy for solo armada milestones and weekly credit math 00:11:24 Blueprint pricing, weekly returns, and the long breakeven conversation 00:14:45 Is the Borg Sphere paywalled content or a grind-to-unlock feature? 00:16:35 Why players are frustrated with a path that could stretch beyond 100 days 00:18:43 How Sphere tasks stack and improve Maverick-credit income over time 00:21:04 Why regular Maverick credits may eventually become surplus 00:23:34 Jules' calculator and planning your credit-spend priorities 00:25:30 Behind-the-scenes pushback that got blueprint costs lowered 00:28:19 Forbidden tech, Chaos Tech, and what actually comes with the ship 00:31:03 Why Suppressors matter now and Obliterators are a later-game accelerator 00:33:17 Is Scopely experimenting with long free-to-play unlock timelines? 00:36:42 Zephyr and Cochrane shard events plus First Contact Day meta 00:38:36 Free refits, instant jump, and whether Assimilate Sting matters 00:40:01 New artifacts, epic Maverick credits, and who they're really for 00:42:12 What non-buyers will still be doing this month in the Maverick loop 00:43:56 Final verdict: the Sphere is a loop-only ship, not an all-rounder 00:45:00 Preview of tonight's follow-up stream and lab testing plans

Jamie Hartmann-Boyce and Nicola Lindson discuss emerging evidence in e-cigarette research and interview Dr Pamela Ling, University of California San Francisco. Associate Professor Jamie Hartmann-Boyce and Associate Professor Nicola Lindson discuss the new evidence in e-cigarette research and interview Dr Pamela Ling, Professor of Medicine and Director of the Center for Tobacco Control Research and Education at the University of California San Francisco. In the March 2026 podcast Pamela Ling talks to Nicola Lindson about her newly published study that recruited approximately 500 13 to 21 year olds to test whether Instagram support groups can help people to quit vaping compared to referral to a quitline. This randomized clinical study was funded by the UCSF Helen Diller Comprehensive Cancer Center and the Tobacco-Related Diseases Research Program and is published in the American Journal of Preventive Medicine. The intervention, Instagram direct message support groups, was delivered over 5 weeks and involved motivational interviewing, social support, skill building, and group quit attempts. The control group was referral to Quitline in California, the resources for this included telephone, online, texting or mobile app. Pam Ling's study found that social media support groups were acceptable to adolescents and young adults and improved abstinence rates on average over 6 months compared to quitline referral. Pam Ling discusses the finding that social media platforms may be a useful way to deliver social supports for nicotine vaping cessation that is accessible and utilised by young people. This podcast is a companion to the electronic cigarettes Cochrane living systematic review and Interventions for quitting vaping review and shares the evidence from the monthly searches. Our searches for the EC for smoking cessation review carried out on 1st March 2026 found: 1 new (Papadosifaki et al, Archives Hellenic Medicine 2026;43(2):205-211) and 3 linked reports (10.1093/ntr/ntag038; 10.1093/sleep/zsag028; 10.1017/S1463423626100942). Our search for our interventions for quitting vaping review carried out on 1st March 2026 found: 1 new (discussed in this podcast 10.1016/j.amepre.2026.108314), 5 linked reports (10.1016/j.acap.2025.103181, 10.1038/s41386-024-02012-z, 10.1186/s40814-026-01782-1, 10.1016/S2468-2667(26)00021-6, 10.1016/S2468-2667(26)00020-4) and 2 new ongoing (ACTRN12626000031369 2026, NCT07392125 2026). For further details see our webpage under 'Monthly search findings': https://www.cebm.ox.ac.uk/research/electronic-cigarettes-for-smoking-cessation-cochrane-living-systematic-review-1 For more information on the full Cochrane review of E-cigarettes for smoking cessation updated in November 2025 see: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010216.pub10/full For more information on the full Cochrane review of Interventions for quitting vaping published in November 2025 see: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD016058.pub3/full This podcast is supported by Cancer Research UK.

PREVIEW FOR LATER. Guest: John Cochrane. Cochrane discusses economic impacts of oil price shocks. He warns that political interference like price controls and taxes fails to increase supply, instead causing shortages, gas lines, and inefficient resource distribution. (1)XERXES THE FIRST OF PERSIA

Intermittent fasting is gaining popularity, promising weight loss and great health benefits. In today's episode, we talk about a new Cochrane review comparing intermittent fasting to regular dieting, to examine how the evidence actually stacks up. Is intermittent fasting all that it claims to be, or just another fad diet? And if you're fasting, how much do you need to pay attention to stuff like protein timing, insulin levels, and when you strength train? *** Do you like what you hear so far? Please leave a five-star review in your podcast player. And hit that follow button! You can also follow us on Instagram. You'll find Daniel at @strengthdan, and Philip at @philipwildenstam. Become a part of our Reddit community here. *** This podcast is brought to you by Styrkelabbet AB, Sweden. To support us, download the world's best gym workout tracker app StrengthLog here. It's completely ad-free and the most generous fitness app on the market, giving you access to unlimited workout logging, lots of workouts and training programs, and much, much more even if you stay a free user for life. If you want a t-shirt with "Train hard, eat well, die anyway", check out our shop here.

In this episode, Chris Cochrane dives into Apple’s $599 MacBook Neo – the cheapest Mac laptop ever made – and whether it spells trouble for Chromebook makers. He also covers Samsung’s CEO blaming AI for rising phone prices, Framework raising RAM prices for the third time in three months, Meta unveiling four custom AI chips, NVIDIA’s GTC 2026 conference preview, a billion-dollar bet against large language models, Microsoft’s game-changing Project Helix Xbox with native Steam support, Windows 11’s new Xbox Mode, and SpaceX gearing up for a critical Starship Flight 12 test. – Want to start a podcast? Its easy to get started! Sign-up at Blubrry – Thinking of buying a Starlink? Use my link to support the show. Subscribe to the Newsletter. Email Chris if you want to get in touch! Like and Follow Geek News Central’s Facebook Page. Support my Show Sponsor: Best Godaddy Promo Codes Get 1Password Apple MacBook Neo The lead story covers Apple’s MacBook Neo. It launched at $599 and marks the cheapest Mac laptop ever made. The device runs on the A18 Pro chip from the iPhone 16 Pro. Cochrane notes a solid market for students, casual users, and anyone who needs a reliable home laptop. However, he advises photographers and videographers to invest in a MacBook Air or Pro instead. The real question remains whether this kills Chromebook sales in education. Samsung CEO Blames AI for Price Hikes Cochrane tackles Samsung’s Galaxy S26 price increases. CEO TM Roh blamed AI infrastructure demand for the hikes. Meanwhile, DDR4 DRAM prices surged sevenfold in a single year. Cochrane points out the irony. Samsung manufactures memory chips, shifted production toward AI data centers, and now cites that same shortage to justify higher consumer prices. He calls the situation “a little shady” but appreciates the transparency. Framework RAM Prices Up Again The RAM crisis extends beyond phones. Framework raised RAM prices for the third consecutive time in three months. Cochrane reinforces advice from a recent episode. He urges listeners to buy now before prices climb further. Analysts project peak prices by mid-2026. The shortage could last through late 2027. Sponsor: GoDaddy Economy hosting $6.99/month, WordPress hosting $12.99/month, domains $11.99. Website builder trial available. Use codes at geeknewscentral.com/godaddy to support the show. Meta Unveils Four Custom AI Chips Cochrane reports on Meta’s four new MTIA chip generations. The company aims to reduce its dependence on NVIDIA by building custom silicon. The MTIA 300 is already in production. New generations will ship every six months through 2027. The chips are built on open-source RISC-V architecture and manufactured by TSMC. NVIDIA GTC 2026 Preview NVIDIA’s GTC conference starts Monday in San Jose. Jensen Huang promises “chips the world has never seen.” Rumored architectures include Rubin Ultra and Feynman. The keynote streams free at nvidia.com on Monday at 11am Pacific. Cochrane notes that while companies like Meta are building chips to escape NVIDIA, competition will eventually catch up. Yann LeCun’s AMI Labs Raises $1.03 Billion Former Meta AI chief Yann LeCun raised $1.03 billion for AMI Labs at a $3.5 billion valuation. It marks the largest European seed round in history for a company just four months old. LeCun is building “world models” that learn from physical reality rather than text. Backers include Jeff Bezos, NVIDIA, and Samsung. Cochrane notes both approaches to AI can coexist. Microsoft Project Helix Microsoft revealed Project Helix at GDC 2026. For the first time, an Xbox will natively support Steam and GOG. Cochrane sees it as both desperate and inevitable. The only reason to buy from the Xbox store would be exclusives. He notes this is a breath of fresh air after months of talk that the Xbox era was ending. Dev kits ship in 2027 with a consumer launch likely late 2027 or 2028. Windows 11 Xbox Mode Microsoft is rolling out Xbox Mode to all Windows 11 PCs in April. The full-screen controller-optimized interface works with Steam, Epic, and Battle.net. Cochrane sees it as the first half of Microsoft’s two-phase gaming strategy. Xbox Mode trains users now. Project Helix delivers dedicated hardware later. He asks whether Sony and Nintendo will follow in Xbox’s footsteps. SpaceX Starship Flight 12 SpaceX announced stacking complete for the next Super Heavy booster at Starbase. Flight 12 targets April and debuts V3 hardware with Raptor 3 engines. Orbital refueling remains the critical unknown for NASA’s Artemis III moon landing. SpaceX has a track record of delivering eventually, just never on Elon’s original timeline. The post Is the MacBook Neo a Chromebook Killer? #1860 appeared first on Geek News Central.

Empowering Lives: Autism, Mental Health, and Healing with Dr. Cochrane In this episode Dr. Cochrane, a renowned psychologist with over three decades of experience. Together, they explore the challenges and strategies for addressing issues faced by neurodivergent individuals and those suffering from trauma. Dr. Cochrane shares her compassionate approach to cognitive behavioral therapy, the importance of self-regulation, and the power of gratitude practice. Through vivid examples, she illustrates the profound impact of vigilant parenting, therapy, and the critical distinction between feelings and facts. This powerful conversation underscores the importance of seeking help and fostering a profound understanding of autism and mental health. Meet Dr. Cochrane: A Renowned Psychologist Understanding Neurodivergence and Therapy Addressing Trauma and Emotional Regulation The Role of Coaching and Therapy Dealing with Psychosis and Severe Mental Health Issues Navigating Relationships and Communication Supporting Children and Teens The Power of Gratitude and Positive Mindset Conclusion and Final Thoughts INTRO/OUTRO: T. Wild Mantor Music BMI The content on Why Not Me: Embracing Autism amd Mental Health Worldwide, including discussions on mental health, autism, and related topics, is provided for informational and entertainment purposes only. The views and opinions expressed by guests are their own and do not reflect those of the podcast, its hosts, or affiliates.Why Not Me is not a medical or mental health professional and does not endorse or verify the accuracy, efficacy, safety of any treatments, programs, or advice discussed.Listeners should consult qualified healthcare professionals, such as licensed therapists, psychologists, or physicians, before making decisions about mental health or autism- related care.Reliance on this podcast's contents is at the listener's own risk. Why Not Me is not liable for any outcomes, financial or otherwise, resulting from actions taken based on the information provided. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Omega-3 fatty acids (particularly EPA and DHA) have a long history in nutrition and cardiovascular medicine, yet the clinical trial literature is often perceived as inconsistent. This episode examines why some randomized trials show clear benefit while others show null or mixed findings, and how differences in trial design, dose, population risk, and outcome selection can materially change what we observe. A key theme is separating (1) the persistent cultural narratives around omega-3s (including origin stories that do not hold up well to modern evidence) from (2) the more precise, mechanistic and clinical questions about where supplemental EPA/DHA may reduce cardiovascular risk. The discussion focuses heavily on understanding heterogeneity: why "omega-3 supplementation" is not a single, uniform exposure, and why subgroup patterns (e.g., secondary prevention, higher baseline triglycerides, and higher doses) may explain much of the apparent conflict in the evidence. Note: This discussion is taken from a previous episode of the podcast. The audio has been remastered and improved, and now study notes and full transcript are available. Timestamps [04:10] Omega-3 historical context and Inuit studies [08:38] Mechanisms of omega-3 benefits [12:49] VITAL and ASCEND trials analysis [23:41] GISSI-Prevenzione trial insights [26:44] REDUCE-IT trial and residual risk [32:19] Significance of baseline triglycerides [37:57] 2018 Cochrane review [46:02] Hu et al. meta-analysis [01:00:27] Practical takeaways for omega-3 supplementation [01:03:55] Key ideas segment (premium subscribers only) Related Resources Go to episode page (with links to mentioned studies) Join the Sigma email newsletter for free Subscribe to Sigma Nutrition Premium Enroll in the next cohort of our Applied Nutrition Literacy course Alan Flanagan's Alinea Nutrition Education Hub

This episode is your rapid-response briefing for Arcfall's First Contact flavor, with DJz, Griffin, and Jules Kern walking players through the new Maverick faction loop and the headline threat: Conqueror Borg Solo Armadas. The crew's mission is clear: cut through early confusion, lay down a practical step-by-step plan, and make sure nobody faceplants into new mechanics on day one. The first “do it now” directive is all about missions. They recommend hitting Warp Dive Bar Part 1 and Part 2 immediately from the gifts tab, because that's where you unlock the building key and get an early stash of directives for the new armadas. In other words: procrastination is cancelled, at least until after your morning coffee and your mission rewards. Then comes the new station building, the Warp Dive Bar, which turns out to be less “cute decoration” and more “the gearbox of the whole arc.” Jules explains the key value: as the building levels up, the store bundles improve in quality while costing the same, meaning early building progression can multiply your overall efficiency. They frame it as a multi-benefit engine: better bundles, more solo-task access, and stronger rep/credit flow over time. On the combat side, the show waves a bright neon warning sign: these Conqueror Borg armadas have a prerequisite “gotcha.” If your armada doesn't include one of each ship type, an instant-kill weapon can trigger, so composition matters before the first shot is even fired. From there, they outline the three big research counters players are being told to prioritize: Isolytic Defense, Apex Shred, and Critical Damage Reduction, plus the broader philosophy of “hit hard, hit fast” while the community figures out optimal crewing and levels. They also clear up a bunch of “what even is this target?” confusion: there are two listed rarities of armadas, but directives and loot remain the same, so it's mostly a difficulty label rather than a loot tier you should obsess over. On the tasking side, Jules calls out that the Conqueror Borg Solo Armada task looks like the most rewarding, and they emphasize coordinating alliance focus so you're not splitting effort across weaker payouts. Finally, the back half of the episode is a tour of this arc's shiny toys: Zephram Cochrane's utility and sourcing considerations, “Transformed Data” and his loot scaling, and a rundown of artifacts that seem pointed at multiple systems (including some G7 open armada support). They close with a crisp day-one checklist: do missions first, source directives, test crews, coordinate tasks, and spend Maverick credits with discipline because you will feel the pinch if you try to buy everything at once.   00:00 – Cold open, caffeine-fueled rollout begins  02:52 – “Everything you need to know” setup: Maverick faction + Conqueror Borg Solo Armadas 05:44 – Warp Dive Bar Part 1 + Part 2 missions: do them immediately (gifts tab), grab directives + building key 08:36 – The Warp Dive Bar arrives (barn-on-a-station vibes), and why it's central to progression 11:28 – Armada “instant kill” warning: bring one of each ship type or get vaporized 14:20 – The three big counters (Isolytic Defense, Apex Shred, Crit Damage Reduction) and why they matter 17:12 – Strategy talk: round cap uncertainty + “hit hard, hit fast,” calibrate levels, start below ops 20:04 – Two “rarities” of armadas: same directives, same loot, mostly a difficulty label 22:56 – Why upgrade the Warp Dive Bar: store bundle quality scales while cost stays the same 25:48 – Building level = multi-benefit engine (more solo tasks, more rep/credits, better store bundles) 28:40 – Timeline check: building parts “shipments,” and the grind-to-20 reality check 31:32 – Alliance task priority: Conqueror Borg Solo Armada task pays way more than the others 34:24 – Participation philosophy: this arc actually looks more playable for more people 37:16 – Store/task loop: keys unlock tasks; tasks feed rep/credits; weekly reset rhythm gets discussed 40:08 – Officer spotlight: Zephram Cochrane sourcing + whole-hull repair utility (and rep scaling) 43:00 – Officer spotlight: “Transformed Data” loot scaling + why he screams “G7 open armadas” 45:52 – Artifacts: Phoenix cockpit (PDP), Cochrane music disc (isolated dmg vs open armadas), priorities 48:44 – Patch-note bomb: more artifacts, many “pay only (this month)” + quick reactions 51:36 – Day-one roadmap begins: missions first, then directives, then smart coordination 54:27 – Final marching orders: pick the right alliance task, don't overspend credits, test crews and share data

This week on The Wellness Scoop, we unpack four headlines shaping how we eat and think about health. A major Cochrane review finds intermittent fasting is no more effective for weight loss than standard calorie-controlled diets, despite its surge in popularity. We explore what the evidence actually shows and why public perception may not match the data. We then dive into resistant starch, the underrated fibre found in foods like lentils and cooled pasta, and explain how simple preparation tweaks can support gut health, cholesterol and blood sugar balance. New research also suggests that lifelong reading, writing and learning could lower dementia risk by nearly 40% and delay onset by up to five years. We unpack what this means for cognitive reserve and long-term brain resilience. And finally, we look at the rise of matcha. From high street launches to social media hype, we break down whether it really deserves its health halo and how it compares to coffee. Order your copy of Ella's new book: ⁠⁠⁠⁠⁠Quick Wins: Healthy Cooking for Busy Lives⁠⁠⁠⁠⁠ Pre-order your copy of Rhi's upcoming book: ⁠⁠⁠⁠⁠The Fibre Formula⁠⁠⁠ Learn more about your ad choices. Visit podcastchoices.com/adchoices

What is "imaginative prayer"? Josh Porter explores the practice of imaginative prayer and shows us how our God-given imagination can become a powerful tool for intimacy with God, showing us how we can use the gift of our imagination as means of encounter with the Trinity.Key Scripture Passages: Romans 12v2; Philippians 4v8; Colossians 3v1-2; John 14v9; John 1v14; Colossians 1v15; Hebrews 12v1-2; Acts 2v17-18This podcast and its episodes are paid for by The Circle, our community of monthly givers. Special thanks for this episode goes to: Julie from Bellingham, Washington; Greg from Pottsboro, Texas; Stephen from Sunnyvale, California; Wilson from Cochrane, Alberta; and Ally from Dallas, Texas. Thank you all so much!If you'd like to pay it forward and contribute toward future resources, you can learn more at practicingtheway.org/give.

In this episode, Ray tackles Anthropic’s standoff with the U.S. Department of War after CEO Daria Amodei refused to grant unrestricted model access, citing concerns over mass surveillance and autonomous weapons. The government responded by banning Anthropic models through administrative orders. Also covered: the top 20 websites of 2026, China’s $173,000 warm-blooded companion robot, Fukushima’s rapidly evolving radioactive hybrid boars, a Chinese spacecraft emergency involving viewport cracks from space debris, Japan’s wooden satellite built with traditional joinery, and human brain cells on a chip that learned to play Doom in just one week. – Want to start a podcast? Its easy to get started! Sign-up at Blubrry – Thinking of buying a Starlink? Use my link to support the show. Subscribe to the Newsletter. Email Ray if you want to get in touch! Like and Follow Geek News Central’s Facebook Page. Support my Show Sponsor: Best Godaddy Promo Codes Get 1Password Full Summary Cochrane opens the show with Anthropic’s confrontation with the U.S. Department of War. CEO Daria Amodei released a public statement refusing unrestricted government access to Anthropic’s AI models. Two red lines stood firm: mass domestic surveillance and fully autonomous weapons. Ray explains that these models are predictive by nature, raising serious misidentification risks. However, the government hit back hard. Administrative orders now ban Anthropic models from government use. Despite the backlash, Cochrane expresses support for the company’s stance. He points listeners to a CBS interview with the CEO posted roughly nine hours before recording. Additionally, Anthropic released new models including Opus 4.5 and Sonnet 4.6. The company climbed to the number two spot on the App Store, trailing only ChatGPT and surpassing Google Gemini. Personal Updates Ray shares that February has been a demanding month. He’s juggling a capstone project, two jobs, and finishing his degree. Meanwhile, he continues working on developments at Blubrry hosting. He apologizes for inconsistent episode production and thanks listeners for their patience. Top 20 Websites of 2026 A Visual Capitalist chart ranks the most visited websites of 2026. Google holds the top spot, followed by YouTube. Facebook, Instagram, ChatGPT, Reddit, Wikipedia, X, and WhatsApp round out the upper rankings. Notably, DuckDuckGo appears at rank seventeen as a privacy-focused search alternative. Sponsor: GoDaddy Economy hosting $6.99/month, WordPress hosting $12.99/month, domains $11.99. Website builder trial available. Use codes at geeknewscentral.com/godaddy to support the show. Anthropic Retires Claude Opus 3 Cochrane discusses Anthropic’s decision to retire Claude Opus 3. In a unique move, the company gave the model a Substack-style blog to reflect on its own existence. Reactions online were mixed, with both supporters and critics engaging in the conversation. China’s $173,000 Warm-Blooded Companion Robot From ZME Science, Ray covers China’s new humanoid robot designed as a warm-blooded companion. Priced at $173,000, it features conventional robotics hardware, sensors, cameras, and autonomous navigation. A built-in heating element maintains body warmth. Cochrane comments humorously on the growing market for companion robots. Windows XP Green Hill Found and Photographed From Tom’s Hardware, someone tracked down and photographed the actual location of the iconic Windows XP “Green Hill” wallpaper. The Reddit post sparked a wave of nostalgia in the community. Fukushima’s Radioactive Hybrid Boars From AZ Animals, domestic pigs that escaped after the Fukushima disaster hybridized with wild boars. Their DNA reveals rapid evolutionary changes driven by the altered radioactive landscape. These aggressive hybrids now complicate wildlife management and rewilding efforts in the region. Shenzhou 20 Spacecraft Emergency Chinese astronauts aboard Shenzhou 20 discovered cracks in their spacecraft’s viewport during what became the nation’s first spaceflight emergency. Space debris likely caused the damage. The crew switched to an alternative return capsule. Multiple protective layers kept the situation manageable. Japan’s Wooden Satellite Japanese teams plan to launch the first wooden satellite. Built with magnolia wood panels assembled using traditional Japanese joinery methods, the biodegradable design aims to reduce aluminum particle pollution from satellites burning up during atmospheric reentry. Human Brain Cells Play Doom Building on previous work where living neurons played Pong, an independent developer used Python to train human brain cell clusters on microelectrode arrays to play Doom. The cells learned in roughly one week. Cochrane highlights how open knowledge sharing accelerated the project dramatically. He also raises ethical questions about training sentient brain cells, connecting the topic to evolving views on sentience in crustaceans and other organisms. The post Anthropic Stands Their Ground, Ethics over Money #1859 appeared first on Geek News Central.

Guest: Grant Newsham. Newsham discusses the PLA purge of leadership, analyzing the implications of Xi Jinping'sremoval of top military officials and what it signals about internal instability within China's armed forces. Guest: Grant Newsham. Newsham critiques the weaknesses of national security studies that expect Chinese attack only at Taiwan, arguing this narrow focus leaves the U.S. vulnerable to broader PRC strategic threats. Guest: John Cochrane. Cochrane analyzes the inadequacy of tariffs as an economic tool, explaining why they fail to achieve their intended goals and often harm domestic consumers and businesses. Guest: John Cochrane. Cochrane discusses the demand for foreign investment, examining how capital flows impact the U.S. economy and the complexities of managing trade imbalances. Guest: Rebecca Grant. Grant compares U.S. carrier capabilities into the future against China's naval expansion plans, assessing the shifting balance of power in the Pacific. Guest: Rick Fisher. Fisher details China's century-long plan for space supremacy, warning that Beijing's strategic investments in space technology pose a significant threat to American dominance. Guest: Steve Yates. Yates examines how allies Australia, Canada, and the UK are seeking favorable trade deals with China, raising concerns about alliance cohesion amid PRC economic pressure. Guest: Steve Yates. Yates discusses strategies for dealing with the PRC as an adversary seeking supremacy, emphasizing the need for coordinated Western responses to Chinese ambitions. Guest: Sinan Ciddi. Ciddi analyzes Erdogan succession prospects in Turkey, examining potential successors and the implications for Turkish domestic and foreign policy. Guest: Sinan Ciddi. Ciddi assesses the possibility of democracy in Turkey, discussing the structural obstacles and political dynamics that shape the country's democratic trajectory. Guest: Sadanand Dhume. Dhume reports on the India-EU trade deal after 21 years of negotiation, analyzing the significance of this agreement for both economies and regional geopolitics. Guest: Michael Bernstam. Bernstam examines Russia's budget gap widening with the sinking price of oil, detailing the fiscal pressures facing Moscow as energy revenues decline. Guest: Simon Constable. Constable reports from France with a resident European pine marten, offering observations on rural life and wildlife in the French countryside. Guest: Simon Constable. Constable discusses the Labour scandal with the Epstein revelations, analyzing the political fallout affecting Britain's governing party. Guest: Bob Zimmerman. Zimmerman reports on Artemis plans for a launch in March, detailing NASA's progress toward returning American astronauts to the Moon. Guest: Bob Zimmerman. Zimmerman analyzes the failing Roscosmos, describing Russia's declining space program and its inability to compete with American and Chinese advancements.

Guest: John Cochrane. Cochrane analyzes the inadequacy of tariffs as an economic tool, explaining why they fail to achieve their intended goals and often harm domestic consumers and businesses1965 SHANGHAI

Guest: John Cochrane. Cochrane discusses the demand for foreign investment, examining how capital flows impact the U.S. economy and the complexities of managing trade imbalances.1925 DUTCH MARINES IN SHANGHAI